var title_f16_12_16576="Medial plica of the knee";
var content_f16_12_16576=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F68856&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F68856&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Medial plica of the knee",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 253px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Medial plica of the knee from an autopsy specimen.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Roberts, WN, Hayes, CW, Breitbach, SA, et al, Am J Med 1996; 100:461.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_12_16576=[""].join("\n");
var outline_f16_12_16576=null;
var title_f16_12_16577="Skin ulcer caused by Fusarium spp";
var content_f16_12_16577=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F61489&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F61489&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Skin ulcer caused by Fusarium spp",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Dr. Marcio Nucci.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_12_16577=[""].join("\n");
var outline_f16_12_16577=null;
var title_f16_12_16578="CCK regulation enzyme release";
var content_f16_12_16578=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F66575&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F66575&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 504px\">",
"   <div class=\"ttl\">",
"    Cholecystokinin (CCK) regulation of enzyme release",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 484px; height: 396px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The presence of fat and protein constituents in the duodenum and proximal jejunum causes the release of CCK from gut endocrine cells. CCK acts directly and through vagal mechanisms to stimulate the release of enzymes from pancreatic acinar cells.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Cleveland Clinic Foundation.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_12_16578=[""].join("\n");
var outline_f16_12_16578=null;
var title_f16_12_16579="Sacrosidase: Pediatric drug information";
var content_f16_12_16579=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Sacrosidase: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?40/41/41619?source=see_link\">",
"    see \"Sacrosidase: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?9/27/9652?source=see_link\">",
"    see \"Sacrosidase: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F219729\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Sucraid&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F219730\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Sucraid&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1061975\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Sucrase Deficiency, Treatment Agent",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1061969\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?40/41/41619?source=see_link\">",
"      see \"Sacrosidase: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Congenital sucrose-isomaltase deficiency (CSID) or sucrase deficiency; oral replacement  (CSID):",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infants and Children &le;15 kg: 8500 international units (1 mL) per meal or snack",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Children &gt;15 kg, Adolescents, and Adults: 17,000 international units (2 mL) per meal or snack",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F219712\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Sucraid&reg;: 8500 units/mL (118 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F219698\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block accres drugH1Div\" id=\"F11234325\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Prescribing and Access Restrictions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Sucraid&reg; is not available in retail pharmacies or via mail-order pharmacies. To obtain the product, please refer to file://www.sucraid.net/how-to-order-sucraid or call 1-866-740-2743.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1061978\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral: Dilute in 2-4 ounces of water, milk, or formula; approximately",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     of the dose may be taken before, and the remainder of the dose at the completion of, each meal or snack; do not administer with fruit juices, warm or hot food or liquids",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1061972\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store at 2&deg;C to 8&deg;C (36&deg;F to 46&deg;F); protect from light; discard 4 weeks after opening",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1061977\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Replacement therapy in congenital sucrase-isomaltase deficiency (CSID) [FDA approved in pediatric patients (age not specified) and adults]",
"    </p>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F219746\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Headache, insomnia, nervousness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Dehydration",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain, constipation, diarrhea, nausea, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Hypersensitivity reactions, wheezing",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1061981\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to sacrosidase or any component, yeast, yeast products, glycerin (glycerol), or papain",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1061968\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in diabetes mellitus; sacrosidase enables absorption of the by-products of sucrose hydrolysis (glucose and fructose); monitor serum glucose; diet and/or insulin dosage may need to be adjusted.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1061967\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity reactions to sacrosidase, including bronchospasm, have been reported; administer initial doses in a setting where acute hypersensitivity reactions may be treated within a few minutes; skin testing may be performed prior to administration to potentially identify patients at risk for hypersensitivity reactions. Product may contain papain; severe hypersensitivity reactions, including anaphylaxis, have been observed with papain exposure. Tachycardia and hypotension, in association with some papain-induced hypersensitivity reactions, have also been observed. In addition, inconclusive data suggests a possible cross-sensitivity may exist between patients with natural rubber latex hypersensitivity and papaya, the source of papain. Use is contraindicated in patients with a known papain hypersensitivity. Oral solution contains 50% glycerol.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300019\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F219707\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F1061984\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Food Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be inactivated or denatured if administered with fruit juice or warm or hot food or liquids; since isomaltase deficiency is not affected by sacrosidase, adherence to a low-starch diet may be required to decrease symptomatology",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F219709\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F219721\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have not been conducted. Should be administered to a pregnant woman only when indicated.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1061974\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Breath hydrogen test, oral sucrose tolerance test, urinary disaccharides, intestinal disaccharidases (measured from small bowel biopsy)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     CSID symptomatology: Diarrhea, abdominal pain, gas, and bloating",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1061966\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Sacrosidase is a naturally occurring GI enzyme derived from baker's yeast",
"     <i>",
"      (Saccharomyces cerevisiae)",
"     </i>",
"     which breaks down the disaccharide sucrose into its monosaccharide components; this hydrolysis is necessary to allow absorption of these nutrients",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1061980\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Metabolism: Sacrosidase is metabolized in the GI tract to individual amino acids which are systemically absorbed",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F1061982\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     1 mL = 22 drops from sacrosidase container tip",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Treem WR, McAdams L, Stanford L, et al, &ldquo;Sacrosidase Therapy for Congenital Sucrose-Isomaltase Deficiency,&rdquo;",
"      <i>",
"       J Pediatr Gastroenterol Nutr",
"      </i>",
"      , 1999, 28(2):137-42.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16579/abstract-text/9932843/pubmed\" id=\"9932843\" target=\"_blank\">",
"        9932843",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12777 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-201.65.114.212-FD0A04FE88-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_12_16579=[""].join("\n");
var outline_f16_12_16579=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F219729\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F219730\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1061975\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1061969\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F219712\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F219698\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11234325\">",
"      Prescribing and Access Restrictions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1061978\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1061972\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1061977\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F219746\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1061981\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1061968\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1061967\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300019\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F219707\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1061984\">",
"      Food Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F219709\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F219721\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1061974\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1061966\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1061980\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1061982\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12777\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12777|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?40/41/41619?source=related_link\">",
"      Sacrosidase: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?9/27/9652?source=related_link\">",
"      Sacrosidase: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_12_16580="Oral lichen planus histopathology - Lichenoid infiltrate";
var content_f16_12_16580=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F86856&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F86856&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Oral lichen planus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 236px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A lichenoid (band-like) infiltrate is present in the submucosa. Subepithelial clefting is also evident.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Dr. Bethanee Schlosser.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_12_16580=[""].join("\n");
var outline_f16_12_16580=null;
var title_f16_12_16581="Tubal preg heartbeat";
var content_f16_12_16581=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F61837&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F61837&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Tubal pregnancy with cardiac activity",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 364px; height: 530px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Transvaginal images show A) a left ovary with corpus luteum (LO) and an adjacent tubal ring (arrow) with internal contents within the sac. B) Closer inspection of the internal contents with m-mode showed cardiac activity in a live ectopic pregnancy.",
"    <div class=\"footnotes\">",
"     CX: cervix.",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Tejas S Mehta, MD, MPH.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_12_16581=[""].join("\n");
var outline_f16_12_16581=null;
var title_f16_12_16582="Bleeding Dieulafoy Endosc";
var content_f16_12_16582=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F73328&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F73328&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Gastric Dieulafoy's lesion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 561px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Active bleeding from a gastric Dieulafoy's lesion (A) along the proximal antrum/anterior wall. The bleeding was controlled with combination endoscopic therapy consisting of: Injection therapy with a 10 French Injector-Gold Probe (Microvasive Corp) using 1:10,000 epinephrine (B), followed by bipolar electrocoagulation at 12 Watts x 10 sec/pulse x 4 pulses using firm tamponade pressure (C), then hemoclipping x 1 (Olympus Corp) (D). India ink tatooing (E) was then performed to mark the treatment site in the event of rebleeding and facilitate localization if surgical intervention (such as wedge resection) is required.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Rome Jutabha, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_12_16582=[""].join("\n");
var outline_f16_12_16582=null;
var title_f16_12_16583="Bile duct injury PSC Light";
var content_f16_12_16583=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F70795&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F70795&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Primary sclerosing cholangitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 445px; height: 287px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Medium power view of a liver biopsy from a patient with primary sclerosing cholangitis shows a portal bile duct with periductal sclerosis associated with degeneration of the bile duct epithelium.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Robert Odze, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_12_16583=[""].join("\n");
var outline_f16_12_16583=null;
var title_f16_12_16584="Fascio-cutaneous blood supply of amputations flaps of the leg";
var content_f16_12_16584=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F53836&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F53836&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 558px\">",
"   <div class=\"ttl\">",
"    Fascio-cutaneous blood supply of amputations flaps of the leg",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 538px; height: 612px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_12_16584=[""].join("\n");
var outline_f16_12_16584=null;
var title_f16_12_16585="Immunity of the newborn";
var content_f16_12_16585=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Immunity of the newborn",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/12/16585/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/12/16585/contributors\">",
"     Ilan Dalal, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/12/16585/contributors\">",
"     Chaim M Roifman, MD, FRCPC, FCACB",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/12/16585/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/12/16585/contributors\">",
"     E Richard Stiehm, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/12/16585/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/12/16585/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/12/16585/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 15, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The fetal immune system develops in a sterile and protected environment, and therefore lacks antigenic experience. It must also be modulated in order to co-exist with the mother's immune system. Soon after birth, the newborn is exposed to the \"hostile world\" of bacteria, viruses, fungi, and parasites, and must immediately defend itself. The immunologic competence of the neonate progresses rapidly in the first three months of life, as the cells involved in acquired immunity mature and gain antigenic experience. During this period, the neonate mainly depends upon components of the innate or antigen-independent immune system, including phagocytes, natural killer cells, antigen presenting cells, humoral mediators of inflammation, and complement [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/1-3\">",
"     1-3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The overall performance of the immune system in the neonatal period is diminished in several important respects. As a result, very young infants are more susceptible than older infants to serious bacterial infection, as well as some viral and fungal infections.",
"   </p>",
"   <p>",
"    Specifically, organisms that can cause significant morbidity in neonates include: group B streptococci, Escherichia coli, herpes simplex virus (HSV), cytomegalovirus (CMV), varicella-zoster virus (VZV), respiratory syncytial virus (RSV), and Candida species [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This review summarizes the current knowledge about the function of the different arms of neonatal immunity, including what is known about neonatal defense against the pathogens mentioned above. More comprehensive reviews are available elsewhere [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/4-7\">",
"     4-7",
"    </a>",
"    ]. Additional information about the development of the cellular components of the immune system is provided separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/32/31242?source=see_link\">",
"     \"The development of immune cells in the fetus and neonate\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Certain clinical scenarios, such as recurrent severe infections, chronic diarrhea, and failure to thrive, should prompt immediate evaluation for immunodeficiency states. The presentation of these disorders is presented in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/30/42471?source=see_link\">",
"     \"Severe combined immunodeficiency (SCID): An overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Clinical information regarding the evaluation and management of fever in neonates is reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/26/28074?source=see_link\">",
"     \"Evaluation and management of fever in the neonate and young infant (less than three months of age)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     LYMPHOCYTES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Certain functions of the adaptive immune response are immature or impaired in the neonate. Leukopenia is seen more commonly in preterm than term infants. In one series, absolute counts of all cord blood immune cell subsets except regulatory T cells were significantly lower in preterm infants compared with term infants [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     T cell-mediated immunity",
"    </span>",
"    &nbsp;&mdash;&nbsp;T cell-mediated immunity is not transferred from mother to fetus, in contrast to humoral immunity. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'B cells and immunoglobulins'",
"    </a>",
"    below.) Thus, young infants rely exclusively on their own T cells plus elements of the innate immune system to fight infections caused by intracellular pathogens, respond to vaccination, and reject foreign tissue.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     The Th1 response",
"    </span>",
"    &nbsp;&mdash;&nbsp;To best understand altered neonatal immune function, a brief review of the Th1 response is useful. Activated T cells may be subdivided into distinct functional categories depending upon the profile of cytokines they secrete [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. The Th1 response promotes production of opsonizing antibodies (eg, IgG1), induction of cellular cytotoxicity, and macrophage activation. This T cell response provides defense against pathogens that replicate intracellularly, particularly mycobacteria and viruses, and also some bacteria and parasites. In comparison, Th2 responses promote the production of IgE and IgG4, and stimulate eosinophil development [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/11,12\">",
"     11,12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The Th1 response is initiated when a pathogen is taken up by a dendritic cell or macrophage and induces the production and secretion of the cytokine interleukin-12 (IL-12). IL-12 both stimulates NK cells and induces naive CD4+ T cells to become Th1-type effector cells. These CD4+T and NK cells produce IFN-gamma, which in turn activates the infected macrophage and initiates the transcription genes within the nucleus [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. Sequelae of IFN-gamma activation on phagocytes include the production of proinflammatory cytokines, such as IL-1beta and tumor necrosis factor alpha (TNF-alpha), and further up-regulation of IL-12 production. IFN-gamma also promotes pathogen killing by macrophages, through an unclear mechanism. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/58/6056?source=see_link\">",
"     \"The adaptive cellular immune response\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The ability of proinflammatory cytokines to induce spontaneous abortion is probably an important reason for the strong bias of the maternal and fetal immune system toward Th2 polarizing cytokines [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/6\">",
"     6",
"    </a>",
"    ]. Delayed maturation of an IL-12 producing dendritic cell subset may explain, at least in part, the early Th2 bias in neonatal immunity [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/15\">",
"     15",
"    </a>",
"    ]. As a consequence, neonates have impaired Th1 responses [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. The production of IFN-gamma (either by CD4+ T cells, NK cells, or both) is reduced compared to that in adults during some, but not all, infections. In addition, neonatal macrophages and mononuclear phagocytes demonstrate reduced or abbreviated responses to IFN-gamma. These differences may contribute to the pathogenesis of several of the infections that disproportionately afflict neonates.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Viral infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although it is reasonable to speculate that infants might be more susceptible than adults to viral infections, most infants overcome viral infections with little difficulty. Nevertheless, certain specific impairments can be demonstrated.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The cytotoxic CD8+ T cell response to CMV is similar in neonates and adults, although the CD4+ T cell response is reduced [",
"      <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/18,19\">",
"       18,19",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Both CD8+ and CD4+ T cells responses to HIV infection appear lower than in adults, probably explaining the rapid progression of the disease in neonates in the absence of anti-retroviral therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/7,20\">",
"       7,20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The neonatal adaptive response to HSV infection is characterized by delayed IFN-gamma production compared to adult cells, possibly accounting for the occasional fulminant infection [",
"      <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/21\">",
"       21",
"      </a>",
"      ]. T regulatory CD4+Foxp3+ cells may contribute to the attenuated primary CD8+ and CD4+ T cell responses to HSV type 2 in neonatal mice [",
"      <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/22\">",
"       22",
"      </a>",
"      ]. In contrast, neonatal NK cells produce the same amount of IFN-gamma when exposed to HSV as adult NK cells [",
"      <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Graft rejection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neonates, including premature infants, are capable of rejecting foreign grafts, solid tissue allografts, bone marrow, and in utero transfusions of irradiated red blood cell from unrelated donors [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/24-28\">",
"     24-28",
"    </a>",
"    ]. Thus, the recognition and response to non-self appears to be functional even in utero.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Vaccination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The neonatal T cell response to some vaccines is reduced, although responses to others may be vigorous. Infants immunized at birth with anti-hepatitis B (HBVac) or oral poliovirus (OPV) vaccines develop Th1 type responses that are lower than those seen in adults [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. In contrast, newborn responses to Bacillus Calmette-Guerin (BCG), the live attenuated Mycobacterium bovis vaccine, are vigorous and comparable to adult responses [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Exposure of cord blood to BCG induces a strong innate response mediated by monocytes and NK cells [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/32\">",
"     32",
"    </a>",
"    ]. IFN-gamma was detected within T cells rather than NK cells in peripheral blood samples collected from infants 13 weeks post-BCG vaccination. This variability may reflect the quality of the signal delivered by antigen presenting cells (APCs) to T cells rather than an intrinsic difference in T cell function. This hypothesis is supported by the observation that BCG immunization (a strong stimulus for APCs) in infants induced higher cytokine and antibody responses to unrelated vaccines given concomitantly [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Delayed-type hypersensitivity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neonates show diminished delayed-type hypersensitivity (DTH) skin test reactions to antigens such as candida and tetanus toxoid, which require the presence of functional antigen presenting cells and antigen-specific CD4+ T cells [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/24,34\">",
"     24,34",
"    </a>",
"    ]. Lack of reactivity generally persists up to one year of age [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     B cells and immunoglobulins",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following is a brief review of issues concerning B cells and immunoglobulin levels in the fetus and newborn. A detailed summary of this issue is presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/36/41544?source=see_link\">",
"     \"Transient hypogammaglobulinemia of infancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In utero, fetal serum immunoglobulin concentrations remain very low (below 100",
"    <span class=\"nowrap\">",
"     mg/dL)",
"    </span>",
"    until 18 to 20 weeks of gestation. Most of the newborn's serum immunoglobulins are derived from the transfer of maternal IgG across the placenta during the third trimester of pregnancy. At birth, neonatal serum IgG levels are equal or slightly higher than maternal serum IgG levels, due to this combination of produced and acquired immunoglobulin.",
"   </p>",
"   <p>",
"    Premature infants have lower IgG concentrations, due to diminished time for transfer and lower production levels. Premature infants of 30 to 32 weeks gestation have cord blood IgG concentrations of only approximately 400",
"    <span class=\"nowrap\">",
"     mg/dL.",
"    </span>",
"    Small for gestational age (SGA) neonates may have somewhat lower IgG levels than full-term neonates, possibly reflecting impaired placental transport. In both premature and SGA infants, concentrations may drop further after birth due to the normal 'physiologic' hypogammaglobulinemia that occurs in all infants.",
"   </p>",
"   <p>",
"    IgA, IgM, IgD, and IgE do not cross the placenta under normal circumstances, and the presence of elevated levels of IgM or IgA in cord blood suggests intrauterine infection [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/36\">",
"     36",
"    </a>",
"    ]. In normal infants, IgM concentration rises rapidly from the first month after birth, presumably in response to the massive antigenic stimulation present in the new environment. However, this IgM may not be as functionally effective as antibodies produced later. Specifically, neonatal IgM may not provide sufficient heat-stable opsonins against gram-negative organisms. Maternally transmitted IgG antibodies serve quite adequately as heat-stable opsonins for most gram-positive bacteria but not for gram-negative organisms. This could explain, in part, the higher frequency of gram-negative infections at this age group. Premature infants, who receive less maternal IgG by the time of birth than term infants, demonstrate low opsonic activity for all types of organisms [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Antibody response to protein antigens",
"    </span>",
"    &nbsp;&mdash;&nbsp;Full-term neonates can produce specific antibodies to T cell-dependent protein antigens, such as tetanus and diphtheria toxoids, hepatitis B surface antigen, and OPV [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. Even premature infants as young as 24 weeks' gestation, as well as SGA infants, respond vigorously to protein vaccines [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/40,41\">",
"     40,41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Antibody response to polysaccharide antigens",
"    </span>",
"    &nbsp;&mdash;&nbsp;In contrast, responses to polysaccharide, T cell-independent antigens, such as the capsular polysaccharides of Hemophilus influenzae type b or Group B streptococci, are severely blunted until approximately 18 to 24 months of age [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/42-44\">",
"     42-44",
"    </a>",
"    ]. The same attenuation has been observed in premature and SGA infants.",
"   </p>",
"   <p>",
"    IgG2, and to a lesser degree, IgG4, are the predominant antibodies produced following natural exposure to polysaccharide antigens. The blunted response to these antigens could be partially explained by the slow rise of IgG2 and IgG4 concentrations after birth (",
"    <a class=\"graphic graphic_figure graphicRef58666 \" href=\"UTD.htm?30/0/30734\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/45\">",
"     45",
"    </a>",
"    ]. Currently, it is not clear whether the increased susceptibility of neonates to infections with polysaccharide bacteria reflects an isolated intrinsic B-cell immaturity, decreased function of other cells such as APCs, or both. Deficiencies in the complement system may also contribute to the poor response to polysaccharide antigens. (See",
"    <a class=\"local\" href=\"#H21\">",
"     'Complement'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Conjugate vaccines were devised to circumvent the poor response to polysaccharide antigens by complexing polysaccharide antigens to immunogenic proteins, thus converting them into T cell-dependent antigens.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     COMPONENTS OF THE INNATE IMMUNE SYSTEM",
"    </span>",
"    &nbsp;&mdash;&nbsp;The",
"    <span class=\"nowrap\">",
"     fetal/newborn",
"    </span>",
"    immune system faces a complex set of physiologic demands, including protection against infection, avoidance of potentially harmful proinflammatory Th1 cytokine responses that can induce alloimmune reactions between the mother and fetus, and balancing the transition from the sterile intrauterine environment to the \"hostile\" world that is rich in foreign pathogens. Newborns must rely on their innate immunity for protection against infection, given the limited exposure to antigens in utero and the relative immaturity of the adaptive immune system [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/46,47\">",
"     46,47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The fetus and the newborn have a unique functional expression of innate immune molecules, including a bias in favor of Th2 polarizing cytokines in the skin and mucosal barriers such as the gastrointestinal and respiratory tracts [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/6,47\">",
"     6,47",
"    </a>",
"    ]. These molecules include chemokines, toll-like receptors (TLRs) that serve to detect the presence of microbes, and cationic membrane-active antimicrobial proteins and peptides (APPs), such as lysozyme, alpha-defensins, ubiquitin, and psoriasin, that have microbicidal and microbial toxin-neutralizing activities.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Antigen presenting cells",
"    </span>",
"    &nbsp;&mdash;&nbsp;The expression of MHC class I and class II molecules by fetal tissues is evident by 12 weeks gestation [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/48\">",
"     48",
"    </a>",
"    ]. Also by this time, all the major APCs, including dendritic cells,",
"    <span class=\"nowrap\">",
"     monocytes/macrophages,",
"    </span>",
"    and B cells are present. Class II expression of neonatal APCs is similar to that of adult cells, whereas Class I MHC expression on neonatal lymphocytes is less intense than that of adult cells [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. The relevance of lower class I MHC expression is unclear, because generation of functional cytolytic CD8+ T cells is intact based on the observation that fetal tissues are vigorously rejected after transplantation into non-MHC matched hosts.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Dendritic cells",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dendritic cells (DCs) are believed to be the primary APCs for naive T cells [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/7\">",
"     7",
"    </a>",
"    ]. Certain properties of neonatal DCs may explain some of the limitations observed in Th1 immunity. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'T cell-mediated immunity'",
"    </a>",
"    above.) Cord blood monocyte-derived dendritic cells express lower levels of HLA-DR, CD1a, and co-stimulatory molecules such as CD40 and CD80 than do adult peripheral cells. As a consequence, these cells show decreased allostimulatory activity for T cells. These cells also have a low capacity to produce IL-12, which may account for the decreased production of INFgamma by neonatal CD4+ T cells after allogeneic stimulation with cord blood monocyte-derived dendritic cells, as compared with adult dendritic cells [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/51,52\">",
"     51,52",
"    </a>",
"    ]. These findings may also help explain the reduced DTH reactivity seen in neonates.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Macrophages",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neonatal macrophages may have decreased responses to pathogen-derived products like lipopolysaccharide (LPS), as well as to stimulatory mediators like INFgamma [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]. LPS normally induces an inflammatory response by signaling through toll-like receptor 4 (TLR-4) complexed to CD14 and MD-2 (an associated extracellular molecule) on the surface of macrophages.",
"   </p>",
"   <p>",
"    Although neonatal cells appear to have normal levels of each component, the signaling that results from the complex is reduced, as is subsequent TNF-alpha production [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]. This may partially explain the occurrence of severe E. coli infections in neonates, since LPS is the primary immunostimulatory component of the bacterial wall of this and other gram negative bacteria.",
"   </p>",
"   <p>",
"    Neonatal monocyte-derived macrophages are substantially less effective at killing Group B streptococci (GBS) and Candida albicans than are adult cells [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/55,56\">",
"     55,56",
"    </a>",
"    ]. Neonatal macrophages can initially phagocytose nonopsonized yeasts normally through innate immune receptors, such as the mannose receptor [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/57,58\">",
"     57,58",
"    </a>",
"    ]. However, ongoing phagocytosis and killing are not sustained in neonatal cells, as demonstrated by a lack of response to IFN-gamma, which enhances and extends killing by adult cells [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Natural killer cells",
"    </span>",
"    &nbsp;&mdash;&nbsp;The percentage of NK cells in cord blood is often slightly lower than in the blood of children and adults; however, the absolute number is approximately the same owing to the higher lymphocyte count in infancy [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/60\">",
"     60",
"    </a>",
"    ]. NK cells are distinct from cytolytic CD8+ T-cells (CTLs) by their capacity to mediate non-MHC restricted natural cytotoxicity [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/61\">",
"     61",
"    </a>",
"    ]. NK cells also kill target cells that are coated with IgG antibodies in a process known as antibody-dependent cellular cytotoxicity (ADCC). NK cells express killer inhibitory receptors (KIRS) that recognize certain MHC antigens and inhibit the killing of normal allogeneic cells.",
"   </p>",
"   <p>",
"    CD56 is an NK cell-specific marker whose presence on the cell surface parallels cytolytic function. Approximately 50 percent of neonatal NK cells are CD56 negative. Consistent with this, the capacity of full term and premature infant cord blood NK cells to mediate cytolysis is roughly one-half (15 to 60 percent in various studies) that of adult NK cells [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/62-64\">",
"     62-64",
"    </a>",
"    ]. Neonatal NK cell ADCC activity is also reduced to approximately 50 percent of adult NK cells [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/64\">",
"     64",
"    </a>",
"    ]. However, when exposed to different cytokines such as IL-2, IL-12, IL-15, and INFgamma, circulating neonatal NK cells increase cytotoxic activity to adult levels [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/65\">",
"     65",
"    </a>",
"    ]. Similarly, when exposed to HSV, INFgamma production is identical in neonatal and adult NK cells [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/23\">",
"     23",
"    </a>",
"    ]. These findings suggest there is no intrinsic abnormality in the NK cells of neonates. Full NK cell function is observed by 9 to 12 months of age.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Neutrophils and monocytes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many aspects of neutrophil and monocyte function appear to be reduced in the neonate.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Neutrophils",
"    </span>",
"    &nbsp;&mdash;&nbsp;The best characterized neutrophil deficit is the limited ability to accelerate neutrophil production in response to infection, mainly due to a diminished bone marrow pool. This is more pronounced in premature infants. Treatment of neonatal sepsis with G-CSF or GM-CSF was studied; although cell counts increased, there was no reduction in mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/66\">",
"     66",
"    </a>",
"    ]. This suggests that the diminished function of these cells is not due to simple deficiency of these growth factors.",
"   </p>",
"   <p>",
"    Other differences compared to adult neutrophil function include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The adhesion of neonatal neutrophils to activated endothelium is 40 to 45 percent that of adult cells. This may be due to decreased expression of the adhesion molecules L-selectin, P-selectin, and the major ligand of P-selectin [",
"      <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/67-70\">",
"       67-70",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/41/17048?source=see_link\">",
"       \"Determinants of neutrophil movement\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Neonatal neutrophil migration is impaired probably because of a decreased capacity to reorganize its cytoskeletal elements such as tubulin and actin in response to stimulation [",
"      <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/71\">",
"       71",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/41/17048?source=see_link\">",
"       \"Determinants of neutrophil movement\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Opsonization and phagocytosis of gram positive and gram negative bacteria by preterm neonatal cells is reduced compared to term and adult cells because levels of opsonins such as IgG, complement, and their receptors are reduced [",
"      <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/72,73\">",
"       72,73",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Complement'",
"      </a>",
"      below and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/31/6650?source=see_link\">",
"       \"Neutrophil functions other than movement\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The bactericidal activity of neonatal neutrophils against most common gram positive and gram negative bacteria is similar to that of adult cells. However, decreased activity has been found against Pseudomonas aeruginosa, Staphylococcus aureus, and some strains of GBS, due to reduced generation of hydroxyl radicals and bactericidal permeability-increasing protein [",
"      <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/74,75\">",
"       74,75",
"      </a>",
"      ]. Some antimicrobial proteins and peptides (APPs) are found in reduced amounts in neonatal neutrophils, including lactoferrin and",
"      <span class=\"nowrap\">",
"       bactericidal/permeability-increasing",
"      </span>",
"      (BPI) protein (approximately 50 and 30 percent of adult levels, respectively), although defensin levels are comparable to that in adults [",
"      <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Overall, neonatal defects in the amplification, mobilization, and function of the neutrophil response may have clinical relevance in that neutropenia is an indicator of poor prognosis in newborns presenting with bacterial sepsis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/76\">",
"     76",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Monocytes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The number of blood monocytes, as well as the capacity to produce monocytes, is similar in neonates and adults [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/77\">",
"     77",
"    </a>",
"    ]. However, the influx of monocytes into sites of inflammation and the subsequent inflammatory response is delayed and attenuated in neonates. This may be caused by diminished chemotaxis, which in one study remained low until six to ten years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/78\">",
"     78",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Neonatal monocytes ingest and kill gram positive and gram negative bacteria as effectively as adult monocytes, although IL-12 production by these cells is lower than adult levels following exposure to group B streptococci [",
"      <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/79-81\">",
"       79-81",
"      </a>",
"      ]. MHC class II expression on monocytes is lower in premature than full-term infants, with a greater decrease seen in infants who become septic, suggesting endotoxin hyporesponsiveness (immunoparalysis) [",
"      <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/3,82\">",
"       3,82",
"      </a>",
"      ]. Also, monocytes from premature infants produce less TNF-alpha, IL-1, and IL-6 in response to LPS than do term monocytes, which could contribute to susceptibility to gram negative bacteria [",
"      <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/83\">",
"       83",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Basal TLR expression of blood monocytes from full-term neonates is similar to that of adults, although the functional consequences of neonatal TLR activation are very different. Neonates have impaired production of the proinflammatory cytokines, TNF-alpha and type I interferons (IFN-alpha and IFN-beta). In contrast, TLR-mediated production of IL-6, IL-10, and IL-23 by neonatal monocytes is actually enhanced relative to adult cells. This polarization is beneficial because excessive production of the proinflammatory cytokines is associated with spontaneous abortion and intrauterine growth retardation. However, it leaves neonates particularly sensitive to infection with a broad array of microorganisms, including intracellular pathogens that require efficient proinflammatory Th1 cell responses for clearance, such as Listeria monocytogenes and herpes simplex virus [",
"      <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The response of cord blood monocytes to VZV may be impaired compared to that of adult monocytes. In one in vitro study, VZV exposure resulted in the release of large amounts of IFN-gamma from adult monocytes, but release from cord blood monocytes was minimal [",
"      <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/1,84\">",
"       1,84",
"      </a>",
"      ]. The importance of this impaired response is illustrated by the severity of varicella infection that occurs in the perinatal period. If the virus is transmitted to the infant before the mother has mounted a protective immune response and passively transferred protective immunoglobulin to the fetus, then the infant is entirely dependent upon innate immunity for protection. Severe infection, with organ involvement and death, may result [",
"      <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/85\">",
"       85",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/11/4278?source=see_link\">",
"       \"Varicella-zoster infection in the newborn\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      RSV can cause severe neonatal pneumonia and bronchiolitis with the highest morbidity during the first six months of life [",
"      <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/86\">",
"       86",
"      </a>",
"      ]. Transplacentally transferred maternal antibody against RSV does not protect neonates against infection. However, cord blood mononuclear cells respond to RSV with the release of various cytokines and chemokines. The profile of the released cytokines differs from that of adult cells, with overproduction of \"innate\" cytokines (particularly IL-6, TNF-alpha, and IL-10) and minimal release of \"adaptive\" cytokines, whereas adult cells released both types of cytokines, suggesting that the adaptive response may be critical for a successful immune defense [",
"      <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/87\">",
"       87",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In contrast to the above examples, the newborn's immune response to HSV-1 may be overly vigorous and contribute to morbidity. Neonatal monocytes produce higher levels of the pro-inflammatory cytokines IL-6 and IL-8 (compared to adult monocytes) in response to stimulation with HSV-1, which is consistent with the exaggerated clinical manifestations of the disease that can be seen [",
"      <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/88,89\">",
"       88,89",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Humoral mediators of inflammation and opsonization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infection and inflammatory responses induce or activate multiple mediators in the plasma, including the components of the complement and kinin systems, mannan-binding lectin, fibronectin, and coagulation factors. Other products, such as the arachidonic acid metabolites, amines, and lysosomal enzymes, are released from leukocytes, endothelial cells, and other cells. Some of these are known to be reduced or altered in the neonate.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Complement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complement component synthesis in the fetus can be detected as early as six to 14 weeks' gestation. There does not appear to be significant maternal transfer of complement proteins across the placenta [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/4,5,90\">",
"     4,5,90",
"    </a>",
"    ]. Term infants have high variability in both classic and alternative pathway activity as well as in levels of individual components of the complement system. Variable decreases in alternative and classical pathway hemolytic activity (AH50 and CH50) may be observed. Preterm infants have a more consistent decrease in these measurements and in levels of C3 and C4, when compared to term infants [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/90,91\">",
"     90,91",
"    </a>",
"    ]. Low C3 levels, as well as reduced levels of complement receptor 2 (CR2, CD21) on B cells, are believed to play a role in the poor response to polysaccharide antigens, as such antigens are capable of activating complement through the alternative pathway [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/92,93\">",
"     92,93",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Antibody response to polysaccharide antigens'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The most significant finding is reduced levels of C9, one of the terminal components needed for the membrane attack complex and bacterial lysis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/94\">",
"     94",
"    </a>",
"    ]. C9 is important for the lysis of certain gram-negative bacteria, such as E. coli K1 [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/95\">",
"     95",
"    </a>",
"    ]. Complement levels increase after birth and reach adult levels between 6 to 18 months of age [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/92\">",
"     92",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/59/11190?source=see_link\">",
"     \"Complement pathways\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Fibronectin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fibronectin is a glycoprotein that augments initial neutrophil adherence to endothelium as part of their migration from blood to the tissues and can act as an opsonin for some bacteria. Plasma fibronectin concentrations are low in neonates, particularly in premature infants and levels increase gradually to adult levels by one year of age [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/96\">",
"     96",
"    </a>",
"    ]. This may contribute to reduced neutrophil function and increased susceptibility to bacterial infections.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Mannose-binding lectin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mannose-binding lectin (MBL) serves as an opsonin for the ingestion of some gram-negative and gram-positive bacteria by neutrophils and monocytes. In premature infants, serum MBL levels are only 50 percent of adult levels. These levels are closer to adult levels in the full-term newborn. There is no known correlation between the reduced levels of these factors and increased risk of infection in neonates [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/97\">",
"     97",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/14/19690?source=see_link\">",
"     \"Mannose-binding lectin deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Adenosine and acute-phase proteins",
"    </span>",
"    &nbsp;&mdash;&nbsp;The metabolic state of the newborn is initially characterized by low oxygen tension that modulates plasma concentrations of early-response cytokines. Such hypoxia is known to increase the production of IL-6 and IL-8 , cytokines with an important role in labor, while limiting production of TNF. Adenosine, a purine metabolite, is also elevated during hypoxia and has immunomodulatory properties through inhibition of TLR-mediated TNF production [",
"    <a class=\"abstract\" href=\"UTD.htm?16/12/16585/abstract/98\">",
"     98",
"    </a>",
"    ]. IL-6 can trigger acute-phase responses by activating hepatocytes to synthesize and secrete an array of acute-phase proteins including mannose-binding lectin, soluble CD14, C reactive protein, and LPS-binding protein. These acute-phase proteins are initially low at birth, but rise during the first week of life.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Infants in the first three months of life are more susceptible than older infants to serious bacterial infection, as well as some viral and fungal infections. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Neonates have some impairment in the Th1 response and show diminished delayed-type hypersensitivity (DTH) skin test reactions up to one year of age. Clinically, they have heightened susceptibility to HIV, CMV, and VZV, although response to other viruses and graft rejection are normal. Responses to some vaccines are vigorous, while those to others are blunted. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'T cell-mediated immunity'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H13\">",
"       'Antigen presenting cells'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most of the newborn's serum immunoglobulins are derived from the transfer of maternal IgG across the placenta during the third trimester of pregnancy. Maternal immunoglobulins are then gradually cleared while antibodies produced by the infant simultaneously increase (",
"      <a class=\"graphic graphic_figure graphicRef58666 \" href=\"UTD.htm?30/0/30734\">",
"       figure 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H9\">",
"       'B cells and immunoglobulins'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Full-term neonates demonstrate strong antibody responses to protein antigens and vaccines. In contrast, responses to polysaccharide antigens are severely blunted until approximately 18 to 24 months of age. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'B cells and immunoglobulins'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Several aspects of neutrophil and monocyte function is reduced in neonates, including a limited ability to accelerate neutrophil production in response to infection or sepsis. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Neutrophils and monocytes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Neonates have high variability in both classic and alternative pathway activity and components, with variable decreases in AH50 and CH50. The most significant finding is reduced levels of C9, one of the terminal components needed for the membrane attack complex and bacterial lysis of certain gram-negative bacteria, such as E. coli. Complement levels increase after birth and reach adult levels between 6 to 18 months of age. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Humoral mediators of inflammation and opsonization'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/1\">",
"      Mar&oacute;di L. Neonatal innate immunity to infectious agents. Infect Immun 2006; 74:1999.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/2\">",
"      PrabhuDas M, Adkins B, Gans H, et al. Challenges in infant immunity: implications for responses to infection and vaccines. Nat Immunol 2011; 12:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/3\">",
"      Ygberg S, Nilsson A. The developing immune system - from foetus to toddler. Acta Paediatr 2012; 101:120.",
"     </a>",
"    </li>",
"    <li>",
"     Lewis B, Wilson CB. Developmental immunology and role of host defenses in fetal and neonatal susceptibility to infection. In: Infectious diseases of the fetus and newborn, 5th ed, Remington JS, Klein JO (Eds), WB Saunders, Philadelphia 2001. p.25.",
"    </li>",
"    <li>",
"     Lewis DB, Wenwei Tu. The physiologic immunodeficiency of immaturity. In: Immunologic disorders in infants and children, 5th ed, Stiehm ER, Ochs HD, Winkelstein JA (Eds), Elsevier Saunders, 2004. p.687.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/6\">",
"      Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 2007; 7:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/7\">",
"      Adkins B, Leclerc C, Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nat Rev Immunol 2004; 4:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/8\">",
"      Correa-Rocha R, P&eacute;rez A, Lorente R, et al. Preterm neonates show marked leukopenia and lymphopenia that are associated with increased regulatory T-cell values and diminished IL-7. Pediatr Res 2012; 71:590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/9\">",
"      Altare F, Jouanguy E, Lamhamedi S, et al. Mendelian susceptibility to mycobacterial infection in man. Curr Opin Immunol 1998; 10:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/10\">",
"      Roesler J, Kofink B, Wendisch J, et al. Listeria monocytogenes and recurrent mycobacterial infections in a child with complete interferon-gamma-receptor (IFNgammaR1) deficiency: mutational analysis and evaluation of therapeutic options. Exp Hematol 1999; 27:1368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/11\">",
"      Chtanova T, Mackay CR. T cell effector subsets: extending the Th1/Th2 paradigm. Adv Immunol 2001; 78:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/12\">",
"      Romagnani S. T-cell subsets (Th1 versus Th2). Ann Allergy Asthma Immunol 2000; 85:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/13\">",
"      Shuai K, Schindler C, Prezioso VR, Darnell JE Jr. Activation of transcription by IFN-gamma: tyrosine phosphorylation of a 91-kD DNA binding protein. Science 1992; 258:1808.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/14\">",
"      Shuai K, Stark GR, Kerr IM, Darnell JE Jr. A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma. Science 1993; 261:1744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/15\">",
"      Lee HH, Hoeman CM, Hardaway JC, et al. Delayed maturation of an IL-12-producing dendritic cell subset explains the early Th2 bias in neonatal immunity. J Exp Med 2008; 205:2269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/16\">",
"      Marodi L. Down-regulation of Th1 responses in human neonates. Clin Exp Immunol 2002; 128:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/17\">",
"      Wilson CB, Lewis DB. Basis and implications of selectively diminished cytokine production in neonatal susceptibility to infection. Rev Infect Dis 1990; 12 Suppl 4:S410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/18\">",
"      Gibson L, Piccinini G, Lilleri D, et al. Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infection. J Immunol 2004; 172:2256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/19\">",
"      Marchant A, Appay V, Van Der Sande M, et al. Mature CD8(+) T lymphocyte response to viral infection during fetal life. J Clin Invest 2003; 111:1747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/20\">",
"      Sandberg JK, Fast NM, Jordan KA, et al. HIV-specific CD8+ T cell function in children with vertically acquired HIV-1 infection is critically influenced by age and the state of the CD4+ T cell compartment. J Immunol 2003; 170:4403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/21\">",
"      Burchett SK, Corey L, Mohan KM, et al. Diminished interferon-gamma and lymphocyte proliferation in neonatal and postpartum primary herpes simplex virus infection. J Infect Dis 1992; 165:813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/22\">",
"      Fernandez MA, Puttur FK, Wang YM, et al. T regulatory cells contribute to the attenuated primary CD8+ and CD4+ T cell responses to herpes simplex virus type 2 in neonatal mice. J Immunol 2008; 180:1556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/23\">",
"      Hayward AR, Herberger M, Saunders D. Herpes simplex virus-stimulated gamma-interferon production by newborn mononuclear cells. Pediatr Res 1986; 20:398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/24\">",
"      Marchant A, Goldman M. T cell-mediated immune responses in human newborns: ready to learn? Clin Exp Immunol 2005; 141:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/25\">",
"      FOWLER R Jr, SCHUBERT WK, WEST CD. Acquired partial tolerance to homologous skin grafts in the human infant at birth. Ann N Y Acad Sci 1960; 87:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/26\">",
"      Rouleau M, Namikawa R, Antonenko S, et al. Antigen-specific cytotoxic T cells mediate human fetal pancreas allograft rejection in SCID-hu mice. J Immunol 1996; 157:5710.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/27\">",
"      Orlandi F, Giambona A, Messana F, et al. Evidence of induced non-tolerance in HLA-identical twins with hemoglobinopathy after in utero fetal transplantation. Bone Marrow Transplant 1996; 18:637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/28\">",
"      Vi&euml;tor HE, Bolk J, Vreugdenhil GR, et al. Alterations in cord blood leukocyte subsets of patients with severe hemolytic disease after intrauterine transfusion therapy. J Pediatr 1997; 130:718.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/29\">",
"      Ota MO, Vekemans J, Schlegel-Haueter SE, et al. Hepatitis B immunisation induces higher antibody and memory Th2 responses in new-borns than in adults. Vaccine 2004; 22:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/30\">",
"      Vekemans J, Ota MO, Wang EC, et al. T cell responses to vaccines in infants: defective IFNgamma production after oral polio vaccination. Clin Exp Immunol 2002; 127:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/31\">",
"      Hussey GD, Watkins ML, Goddard EA, et al. Neonatal mycobacterial specific cytotoxic T-lymphocyte and cytokine profiles in response to distinct BCG vaccination strategies. Immunology 2002; 105:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/32\">",
"      Watkins ML, Semple PL, Abel B, et al. Exposure of cord blood to Mycobacterium bovis BCG induces an innate response but not a T-cell cytokine response. Clin Vaccine Immunol 2008; 15:1666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/33\">",
"      Ota MO, Vekemans J, Schlegel-Haueter SE, et al. Influence of Mycobacterium bovis bacillus Calmette-Gu&eacute;rin on antibody and cytokine responses to human neonatal vaccination. J Immunol 2002; 168:919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/34\">",
"      WARWICK WJ, GOOD RA, SMITH RT. Failure of passive transfer of delayed hypersensitivity in the newborn human infant. J Lab Clin Med 1960; 56:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/35\">",
"      Kniker WT, Lesourd BM, McBryde JL, Corriel RN. Cell-mediated immunity assessed by Multitest CMI skin testing in infants and preschool children. Am J Dis Child 1985; 139:840.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/36\">",
"      Alford CA Jr, Stagno S, Reynolds DW. Diagnosis of chronic perinatal infections. Am J Dis Child 1975; 129:455.",
"     </a>",
"    </li>",
"    <li>",
"     Buckley RH. The immunologic system and disorders. In: Nelson's textbook of pediatrics, Behrman RE, Kliegman RM, Jenson HB (Eds), WB Saunders, Philadelphia 2004. p.681.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/38\">",
"      Bernbaum JC, Daft A, Anolik R, et al. Response of preterm infants to diphtheria-tetanus-pertussis immunizations. J Pediatr 1985; 107:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/39\">",
"      Adenyi-Jones SC, Faden H, Ferdon MB, et al. Systemic and local immune responses to enhanced-potency inactivated poliovirus vaccine in premature and term infants. J Pediatr 1992; 120:686.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/40\">",
"      Smolen P, Bland R, Heiligenstein E, et al. Antibody response to oral polio vaccine in premature infants. J Pediatr 1983; 103:917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/41\">",
"      Koblin BA, Townsend TR, Mu&ntilde;oz A, et al. Response of preterm infants to diphtheria-tetanus-pertussis vaccine. Pediatr Infect Dis J 1988; 7:704.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/42\">",
"      Adderson EE, Shackelford PG, Quinn A, Carroll WL. Restricted Ig H chain V gene usage in the human antibody response to Haemophilus influenzae type b capsular polysaccharide. J Immunol 1991; 147:1667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/43\">",
"      Landers CD, Chelvarajan RL, Bondada S. The role of B cells and accessory cells in the neonatal response to TI-2 antigens. Immunol Res 2005; 31:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/44\">",
"      Smith DH, Peter G, Ingram DL, et al. Responses of children immunized with the capsular polysaccharide of Hemophilus influenzae, type b. Pediatrics 1973; 52:637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/45\">",
"      Dalal I, Reid B, Nisbet-Brown E, Roifman CM. The outcome of patients with hypogammaglobulinemia in infancy and early childhood. J Pediatr 1998; 133:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/46\">",
"      Tosi MF. Innate immune responses to infection. J Allergy Clin Immunol 2005; 116:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/47\">",
"      Belderbos M, Levy O, Bont L. Neonatal innate immunity in allergy development. Curr Opin Pediatr 2009; 21:762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/48\">",
"      Hofman FM, Danilovs JA, Taylor CR. HLA-DR (Ia)-positive dendritic-like cells in human fetal nonlymphoid tissues. Transplantation 1984; 37:590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/49\">",
"      Keever CA, Abu-Hajir M, Graf W, et al. Characterization of the alloreactivity and anti-leukemia reactivity of cord blood mononuclear cells. Bone Marrow Transplant 1995; 15:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/50\">",
"      Harvey J, Jones DB, Wright DH. Differential expression of MHC- and macrophage-associated antigens in human fetal and postnatal small intestine. Immunology 1990; 69:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/51\">",
"      Goriely S, Vincart B, Stordeur P, et al. Deficient IL-12(p35) gene expression by dendritic cells derived from neonatal monocytes. J Immunol 2001; 166:2141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/52\">",
"      De Wit D, Olislagers V, Goriely S, et al. Blood plasmacytoid dendritic cell responses to CpG oligodeoxynucleotides are impaired in human newborns. Blood 2004; 103:1030.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/53\">",
"      Levy O, Zarember KA, Roy RM, et al. Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848. J Immunol 2004; 173:4627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/54\">",
"      Yan SR, Qing G, Byers DM, et al. Role of MyD88 in diminished tumor necrosis factor alpha production by newborn mononuclear cells in response to lipopolysaccharide. Infect Immun 2004; 72:1223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/55\">",
"      Mar&oacute;di L, K&aacute;poszta R, Nemes E. Survival of group B streptococcus type III in mononuclear phagocytes: differential regulation of bacterial killing in cord macrophages by human recombinant gamma interferon and granulocyte-macrophage colony-stimulating factor. Infect Immun 2000; 68:2167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/56\">",
"      Bektas S, Goetze B, Speer CP. Decreased adherence, chemotaxis and phagocytic activities of neutrophils from preterm neonates. Acta Paediatr Scand 1990; 79:1031.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/57\">",
"      Ezekowitz RA, Sastry K, Bailly P, Warner A. Molecular characterization of the human macrophage mannose receptor: demonstration of multiple carbohydrate recognition-like domains and phagocytosis of yeasts in Cos-1 cells. J Exp Med 1990; 172:1785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/58\">",
"      Mar&oacute;di L, Korchak HM, Johnston RB Jr. Mechanisms of host defense against Candida species. I. Phagocytosis by monocytes and monocyte-derived macrophages. J Immunol 1991; 146:2783.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/59\">",
"      D'Ambola JB, Sherman MP, Tashkin DP, Gong H Jr. Human and rabbit newborn lung macrophages have reduced anti-Candida activity. Pediatr Res 1988; 24:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/60\">",
"      Shearer WT, Rosenblatt HM, Gelman RS, et al. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol 2003; 112:973.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/61\">",
"      Phillips JH, Hori T, Nagler A, et al. Ontogeny of human natural killer (NK) cells: fetal NK cells mediate cytolytic function and express cytoplasmic CD3 epsilon,delta proteins. J Exp Med 1992; 175:1055.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/62\">",
"      Baley JE, Schacter BZ. Mechanisms of diminished natural killer cell activity in pregnant women and neonates. J Immunol 1985; 134:3042.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/63\">",
"      Nair MP, Schwartz SA, Menon M. Association of decreased natural and antibody-dependent cellular cytotoxicity and production of natural killer cytotoxic factor and interferon in neonates. Cell Immunol 1985; 94:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/64\">",
"      Merrill JD, Sigaroudinia M, Kohl S. Characterization of natural killer and antibody-dependent cellular cytotoxicity of preterm infants against human immunodeficiency virus-infected cells. Pediatr Res 1996; 40:498.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/65\">",
"      Kohl S. Human neonatal natural killer cell cytotoxicity function. Pediatr Infect Dis J 1999; 18:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/66\">",
"      Miura E, Procianoy RS, Bittar C, et al. A randomized, double-masked, placebo-controlled trial of recombinant granulocyte colony-stimulating factor administration to preterm infants with the clinical diagnosis of early-onset sepsis. Pediatrics 2001; 107:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/67\">",
"      Teng P, Cao Y, Wang WX, et al. [The shh promoter of zebrafish directs the expression of GFP in notochord]. Yi Chuan Xue Bao 2004; 31:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/68\">",
"      Koenig JM, Simon J, Anderson DC, et al. Diminished soluble and total cellular L-selectin in cord blood is associated with its impaired shedding from activated neutrophils. Pediatr Res 1996; 39:616.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/69\">",
"      Lorant DE, Li W, Tabatabaei N, et al. P-selectin expression by endothelial cells is decreased in neonatal rats and human premature infants. Blood 1999; 94:600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/70\">",
"      Tcharmtchi MH, Smith CW, Mariscalco MM. Neonatal neutrophil interaction with P-selectin: contribution of P-selectin glycoprotein ligand-1 and sialic acid. J Leukoc Biol 2000; 67:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/71\">",
"      Merry C, Puri P, Reen DJ. Defective neutrophil actin polymerisation and chemotaxis in stressed newborns. J Pediatr Surg 1996; 31:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/72\">",
"      Falconer AE, Carr R, Edwards SW. Impaired neutrophil phagocytosis in preterm neonates: lack of correlation with expression of immunoglobulin or complement receptors. Biol Neonate 1995; 68:264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/73\">",
"      Fujiwara T, Kobayashi T, Takaya J, et al. Plasma effects on phagocytic activity and hydrogen peroxide production by polymorphonuclear leukocytes in neonates. Clin Immunol Immunopathol 1997; 85:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/74\">",
"      Stroobant J, Harris MC, Cody CS, et al. Diminished bactericidal capacity for group B Streptococcus in neutrophils from \"stressed\" and healthy neonates. Pediatr Res 1984; 18:634.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/75\">",
"      Levy O, Martin S, Eichenwald E, et al. Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal/permeability-increasing protein. Pediatrics 1999; 104:1327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/76\">",
"      Molloy EJ, O'Neill AJ, Grantham JJ, et al. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor have differential effects on neonatal and adult neutrophil survival and function. Pediatr Res 2005; 57:806.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/77\">",
"      Ueno Y, Koizumi S, Yamagami M, et al. Characterization of hemopoietic stem cells (CFUc) in cord blood. Exp Hematol 1981; 9:716.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/78\">",
"      Klein RB, Fischer TJ, Gard SE, et al. Decreased mononuclear and polymorphonuclear chemotaxis in human newborns, infants, and young children. Pediatrics 1977; 60:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/79\">",
"      Becker ID, Robinson OM, Baz&aacute;n TS, et al. Bactericidal capacity of newborn phagocytes against group B beta-hemolytic streptococci. Infect Immun 1981; 34:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/80\">",
"      Conly ME, Speert DP. Human neonatal monocyte-derived macrophages and neutrophils exhibit normal nonopsonic and opsonic receptor-mediated phagocytosis and superoxide anion production. Biol Neonate 1991; 60:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/81\">",
"      Joyner JL, Augustine NH, Taylor KA, et al. Effects of group B streptococci on cord and adult mononuclear cell interleukin-12 and interferon-gamma mRNA accumulation and protein secretion. J Infect Dis 2000; 182:974.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/82\">",
"      Azizia M, Lloyd J, Allen M, et al. Immune status in very preterm neonates. Pediatrics 2012; 129:e967.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/83\">",
"      Bessler H, Mendel C, Straussberg R, et al. Effects of dexamethasone on IL-1beta, IL-6, and TNF-alpha production by mononuclear cells of newborns and adults. Biol Neonate 1999; 75:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/84\">",
"      Yu HR, Chang JC, Chen RF, et al. Different antigens trigger different Th1/Th2 reactions in neonatal mononuclear cells (MNCs) relating to T-bet/GATA-3 expression. J Leukoc Biol 2003; 74:952.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/85\">",
"      Brunell PA. Fetal and neonatal varicella-zoster infections. Semin Perinatol 1983; 7:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/86\">",
"      Parrott RH, Kim HW, Arrobio JO, et al. Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex. Am J Epidemiol 1973; 98:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/87\">",
"      Krishnan S, Craven M, Welliver RC, et al. Differences in participation of innate and adaptive immunity to respiratory syncytial virus in adults and neonates. J Infect Dis 2003; 188:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/88\">",
"      Kurt-Jones EA, Belko J, Yu C, et al. The role of toll-like receptors in herpes simplex infection in neonates. J Infect Dis 2005; 191:746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/89\">",
"      Schultz C, Rott C, Temming P, et al. Enhanced interleukin-6 and interleukin-8 synthesis in term and preterm infants. Pediatr Res 2002; 51:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/90\">",
"      Johnston RB Jr, Altenburger KM, Atkinson AW Jr, Curry RH. Complement in the newborn infant. Pediatrics 1979; 64:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/91\">",
"      Drossou V, Kanakoudi F, Diamanti E, et al. Concentrations of main serum opsonins in early infancy. Arch Dis Child Fetal Neonatal Ed 1995; 72:F172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/92\">",
"      Davis CA, Vallota EH, Forristal J. Serum complement levels in infancy: age related changes. Pediatr Res 1979; 13:1043.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/93\">",
"      Tasker L, Marshall-Clarke S. Functional responses of human neonatal B lymphocytes to antigen receptor cross-linking and CpG DNA. Clin Exp Immunol 2003; 134:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/94\">",
"      Wolach B, Dolfin T, Regev R, et al. The development of the complement system after 28 weeks' gestation. Acta Paediatr 1997; 86:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/95\">",
"      Lassiter HA, Watson SW, Seifring ML, Tanner JE. Complement factor 9 deficiency in serum of human neonates. J Infect Dis 1992; 166:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/96\">",
"      Barnard DR, Arthur MM. Fibronectin (cold insoluble globulin) in the neonate. J Pediatr 1983; 102:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/97\">",
"      Lau YL, Chan SY, Turner MW, et al. Mannose-binding protein in preterm infants: developmental profile and clinical significance. Clin Exp Immunol 1995; 102:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/12/16585/abstract/98\">",
"      Hask&oacute; G, Cronstein BN. Adenosine: an endogenous regulator of innate immunity. Trends Immunol 2004; 25:33.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5952 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-122.72.76.133-ADE86C94E6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_12_16585=[""].join("\n");
var outline_f16_12_16585=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H25\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      LYMPHOCYTES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      T cell-mediated immunity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - The Th1 response",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Viral infections",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Graft rejection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Vaccination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Delayed-type hypersensitivity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      B cells and immunoglobulins",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Antibody response to protein antigens",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Antibody response to polysaccharide antigens",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      COMPONENTS OF THE INNATE IMMUNE SYSTEM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Antigen presenting cells",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Dendritic cells",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Macrophages",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Natural killer cells",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Neutrophils and monocytes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Neutrophils",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Monocytes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Humoral mediators of inflammation and opsonization",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Complement",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Fibronectin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Mannose-binding lectin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Adenosine and acute-phase proteins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/5952\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/5952|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?30/0/30734\" title=\"figure 1\">",
"      Normal IgG subclass levels in infants and children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/59/11190?source=related_link\">",
"      Complement pathways",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/41/17048?source=related_link\">",
"      Determinants of neutrophil movement",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/26/28074?source=related_link\">",
"      Evaluation and management of fever in the neonate and young infant (less than three months of age)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/14/19690?source=related_link\">",
"      Mannose-binding lectin deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/31/6650?source=related_link\">",
"      Neutrophil functions other than movement",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/30/42471?source=related_link\">",
"      Severe combined immunodeficiency (SCID): An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/58/6056?source=related_link\">",
"      The adaptive cellular immune response",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/32/31242?source=related_link\">",
"      The development of immune cells in the fetus and neonate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/36/41544?source=related_link\">",
"      Transient hypogammaglobulinemia of infancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/11/4278?source=related_link\">",
"      Varicella-zoster infection in the newborn",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_12_16586="Fluconazole: Drug information";
var content_f16_12_16586=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Fluconazole: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?29/4/29765?source=see_link\">",
"    see \"Fluconazole: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/43/26297?source=see_link\">",
"    see \"Fluconazole: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F171677\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Diflucan&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F171678\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Fluconazole&reg;;",
"     </li>",
"     <li>",
"      CanesOral&reg;;",
"     </li>",
"     <li>",
"      CO Fluconazole;",
"     </li>",
"     <li>",
"      Diflucan&reg;;",
"     </li>",
"     <li>",
"      Dom-Fluconazole;",
"     </li>",
"     <li>",
"      Fluconazole Injection;",
"     </li>",
"     <li>",
"      Fluconazole Omega;",
"     </li>",
"     <li>",
"      Monicure;",
"     </li>",
"     <li>",
"      Mylan-Fluconazole;",
"     </li>",
"     <li>",
"      Novo-Fluconazole;",
"     </li>",
"     <li>",
"      PHL-Fluconazole;",
"     </li>",
"     <li>",
"      PMS-Fluconazole;",
"     </li>",
"     <li>",
"      PRO-Fluconazole;",
"     </li>",
"     <li>",
"      Riva-Fluconazole;",
"     </li>",
"     <li>",
"      Taro-Fluconazole;",
"     </li>",
"     <li>",
"      ZYM-Fluconazole",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F171730\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antifungal Agent, Oral;",
"     </li>",
"     <li>",
"      Antifungal Agent, Parenteral",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F171682\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The daily dose of fluconazole is the same for both oral and I.V. administration",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Usual dosage range:",
"     </b>",
"     Oral, I.V: 150 mg once",
"     <b>",
"      or",
"     </b>",
"     Loading dose: 200-800 mg; maintenance: 200-800 mg once daily; duration and dosage depend on location and severity of infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">",
"     <b>",
"      Indication-specific dosing:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     <b>",
"      Blastomycosis (unlabeled use):",
"     </b>",
"     Oral:",
"     <i>",
"      CNS disease:",
"     </i>",
"     Consolidation: 800 mg daily for &ge;12 months and until resolution of CSF abnormalities (Chapman, 2008)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Candidiasis:",
"     </b>",
"     Oral, I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <i>",
"      Candidemia (neutropenic and non-neutropenic):",
"     </i>",
"     Loading dose: 800 mg (12 mg/kg) on day 1, then 400 mg daily (6 mg/kg/day) for 14 days after first negative blood culture and resolution of signs/symptoms.",
"     <b>",
"      Note:",
"     </b>",
"     Not recommended for patients with recent azole exposure, critical illness, or if",
"     <i>",
"      C. krusei",
"     </i>",
"     or",
"     <i>",
"      C. glabrata",
"     </i>",
"     are suspected (Pappas, 2009).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <i>",
"      Chronic, disseminated:",
"     </i>",
"     400 mg daily  (6 mg/kg/day) until calcification or lesion resolution (Pappas, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <i>",
"      CNS candidiasis (alternative therapy):",
"     </i>",
"     400-800 mg daily (6-12 mg/kg/day) until CSF/radiological abnormalities resolved.",
"     <b>",
"      Note:",
"     </b>",
"     Recommended as alternative therapy in patients intolerant of amphotericin B (Pappas, 2009).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <i>",
"      Endocarditis, prosthetic valve (unlabeled use):",
"     </i>",
"     400-800 mg daily (6-12 mg/kg/day) for 6 weeks after valve replacement (as step-down in stable, culture-negative patients); long-term suppression in absence of valve replacement: 400-800 mg daily (Pappas, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <i>",
"      Endophthalmitis (unlabeled use):",
"     </i>",
"     400-800 mg daily (6-12 mg/kg/day) for 4-6 weeks until examination indicates resolution (Pappas, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <i>",
"      Esophageal:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Manufacturer&rsquo;s recommendation: Loading dose: 200 mg on day 1, then maintenance dose of 100-400 mg daily for 21 days and for at least 2 weeks following resolution of symptoms",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Alternative dosing: 200-400 mg daily for 14-21 days; suppressive therapy of 100-200 mg 3 times weekly may be used for recurrent infections (Pappas, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <i>",
"      Intertrigo (unlabeled use):",
"     </i>",
"     50 mg daily or 150 mg once weekly  (Coldiron, 1991; Nozickova, 1998; Stengel, 1994)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <i>",
"      Oropharyngeal:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Manufacturer&rsquo;s recommendation: Loading dose: 200 mg on day 1; maintenance dose 100 mg daily for &ge;2 weeks.",
"     <b>",
"      Note:",
"     </b>",
"     Therapy with 100 mg daily is associated with resistance development (Rex, 1995).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Alternative dosing: 100-200 mg daily for 7-14 days for uncomplicated, moderate-to-severe disease; chronic therapy of 100 mg 3 times weekly is recommended in immunocompromised patients with history of oropharyngeal candidiasis (OPC) (Pappas, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <i>",
"      Osteoarticular:",
"     </i>",
"     400 mg daily for 6-12 months (osteomyelitis) or 6 weeks (septic arthritis) (Pappas, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <i>",
"      Pacemaker (or ICD, VAD) infection (unlabeled use):",
"     </i>",
"     400-800 mg daily (6-12 mg/kg/day) for 4- 6 weeks after device removal (as step-down in stable, culture-negative patients); long-term suppression when VAD cannot be removed: 400-800 mg daily (Pappas, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <i>",
"      Pericarditis or myocarditis:",
"     </i>",
"     400-800 mg daily for several months (Pappas, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <i>",
"      Peritonitis:",
"     </i>",
"     50-200 mg daily.",
"     <b>",
"      Note:",
"     </b>",
"     Some clinicians do not recommend using &lt;200 mg daily (Chen, 2004).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <i>",
"      Prophylaxis:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Bone marrow transplant: 400 mg once daily. Patients anticipated to have severe granulocytopenia should start therapy several days prior to the anticipated onset of neutropenia and continue for 7 days after the neutrophil count is &gt;1000 mm",
"     <sup>",
"      3",
"     </sup>",
"     .",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     High-risk ICU patients in units with high incidence of invasive candidiasis: 400 mg once daily (Pappas, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Neutropenic patients: 400 mg once daily for duration of neutropenia (Pappas, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Peritoneal dialysis associated infection (concurrently treated with antibiotics), prevention of secondary fungal infection: 200 mg every 48 hours (Restrepo, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Solid organ transplant: 200-400 mg once daily for at least 7-14 days (Pappas, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <i>",
"      Thrombophlebitis, suppurative (unlabeled use):",
"     </i>",
"     400-800 mg daily (6-12 mg/kg/day) and as step-down in stable patients for &ge;2 weeks (Pappas, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <i>",
"      Urinary tract:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Cystitis:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Manufacturer&rsquo;s recommendation: UTI: 50-200 mg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     Asymptomatic, patient undergoing urologic procedure: 200-400 mg once daily several days before and after the procedure (Pappas, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     Symptomatic: 200 mg once daily for 2 weeks (Pappas, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Fungus balls: 200-400 mg once daily (Pappas, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Pyelonephritis: 200-400 mg once daily for 2 weeks (Pappas, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <i>",
"      Vaginal:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Uncomplicated: Manufacturer&rsquo;s recommendation: 150 mg as a single oral dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Complicated: 150 mg every 72 hours for 3 doses (Pappas, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Recurrent: 150 mg once daily for 10-14 days, followed by 150 mg once weekly for 6 months (Pappas, 2009),",
"     <b>",
"      or",
"     </b>",
"     fluconazole (oral) 100 mg, 150 mg, or 200 mg every third day for a total of 3 doses (day 1, 4, and 7), then 100 mg, 150 mg, or 200 mg dose weekly for 6 months (CDC, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Coccidioidomycosis, treatment:",
"     </b>",
"     Oral, I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <i>",
"      HIV-infected (unlabeled use):",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Meningitis: 400-800 mg once daily continued indefinitely (CDC, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Pneumonia, focal, mild or positive serology alone: 400 mg once daily continued indefinitely (CDC, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Pneumonia, diffuse or severe extrathoracic disseminated disease (after clinical improvement noted with amphotericin B): 400 mg once daily (CDC, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <i>",
"      Non-HIV infected (unlabeled use):",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Disseminated, extrapulmonary: 400 mg once daily (some experts use 2000 mg daily [Galgiani, 2005])",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Meningitis: 400 mg once daily (some experts use initial doses of 800-1000 mg daily), lifelong duration (Galgiani, 2005)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Pneumonia, acute, uncomplicated: 200-400 mg daily for 3-6 months (Catanzaro, 1995; Galgiani, 2000)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Pneumonia, chronic progressive, fibrocavitary: 200-400 mg daily for 12 months (Catanzaro, 1995; Galgiani, 2000)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Pneumonia, diffuse: Consolidation after amphotericin B induction: 400 mg daily for 12 months (lifelong in chronically immunosuppressed) (Galgiani, 2005)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Coccidioidomycosis, prophylaxis:",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <i>",
"      HIV-infected, positive serology, CD4+ count &lt;250 cells/microL (unlabeled use):",
"     </i>",
"     400 mg once daily (CDC, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <i>",
"      Solid organ transplant (unlabeled use):",
"     </i>",
"     <b>",
"      Note:",
"     </b>",
"     Prophylaxis regimens in this setting have not been established; the following regimen has been proposed for transplant recipients who maintain residence in a",
"     <i>",
"      Coccidioides",
"     </i>",
"     spp endemic area.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Previous history &gt;12 months prior to transplant: 200 mg once daily for 6-12 months (Vikram, 2009; Vucicevic, 2011)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Previous history &le;12 months prior to transplant: 400 mg once daily, lifelong treatment (Vikram, 2009; Vucicevic, 2011)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Positive serology before or at transplant: 400 mg once daily, lifelong treatment; if serology is negative at 12 months, consider a dose reduction to 200 mg daily (Vikram, 2009; Vucicevic, 2011)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     No history (at risk for",
"     <i>",
"      de novo",
"     </i>",
"     post-transplant disease): some clinicians treat with 200 mg daily for 6-12 months (Vucicevic, 2011)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Cryptococcosis:",
"     </b>",
"     Oral, I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <i>",
"      Meningitis:",
"     </i>",
"     Manufacturer&rsquo;s recommendation: 400 mg for 1 dose, then 200-400 mg once daily for 10-12 weeks following negative CSF culture",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <i>",
"      HIV-infected:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Meningitis (in patients amphotericin B resistant or intolerant): Induction: 400-800 mg once daily for 4-6 weeks with concomitant flucytosine (CDC, 2009)",
"     <b>",
"      or",
"     </b>",
"     800-1200 mg once daily with concomitant flucytosine for 6 weeks (Perfect, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Consolidation: 400 mg once daily for 8 weeks (CDC, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Maintenance (suppression): 200 mg once daily lifelong or until CD4+ count &gt;200 (CDC, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <i>",
"      Pulmonary (immunocompetent) (unlabeled use):",
"     </i>",
"     400 mg once daily for 6-12 months (Perfect, 2010)",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F171707\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/43/26297?source=see_link\">",
"      see \"Fluconazole: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The daily dose of fluconazole is the same for oral and I.V. administration",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Usual dosage range:",
"     </b>",
"     Oral, I.V: Loading dose: 6-12 mg/kg/dose; maintenance: 3-12 mg/kg/dose once daily; duration and dosage depend on location and severity of infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">",
"     <b>",
"      Indication-specific dosing:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Candidiasis:",
"     </b>",
"     Oral, I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Esophageal:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Manufacturer&rsquo;s recommendation: Loading dose: 6 mg/kg/dose; maintenance: 3-12 mg/kg/dose once daily for 21 days and for at least 2 weeks following resolution of symptoms (maximum: 600 mg/day)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     HIV-exposed/-infected: Loading dose: 6 mg/kg/dose once on day 1; maintenance: 3-6 mg/kg/dose once daily for 4-21 days (maximum: 400 mg/day) (CDC, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Relapse suppression (HIV-exposed/-infected): 3-6 mg/kg/dose once daily (maximum: 200 mg/day) (CDC, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     Invasive disease (alternative therapy): 5-6 mg/kg/dose every 12 hours for &ge;28 days (maximum: 600 mg/day) (CDC, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Oropharyngeal:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Manufacturer&rsquo;s recommendation: Loading dose: 6 mg/kg/dose; maintenance: 3 mg/kg/dose once daily for &ge;2 weeks (maximum: 600 mg/day)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     HIV-exposed/-infected: 3-6 mg/kg/dose once daily for 7-14 days (maximum: 400 mg/day) (CDC, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Coccidiodomycosis:",
"     </b>",
"     Oral, I.V.:",
"     <i>",
"      Meningeal infection, or in a stable patient with diffuse pulmonary or disseminated disease",
"     </i>",
"     (HIV-exposed/-infected):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Treatment: 5-6 mg/kg/dose twice daily (maximum daily dose: 800 mg/",
"     <b>",
"      day",
"     </b>",
"     ) (CDC, 2009) followed by chronic suppressive therapy (see below)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Relapse suppression: 6 mg/kg/dose once daily (maximum daily dose: 400 mg/",
"     <b>",
"      day",
"     </b>",
"     ) (CDC, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Cryptococcosis:",
"     </b>",
"     Oral, I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Meningitis:",
"     </i>",
"     Manufacturer&rsquo;s recommendation:: 12 mg/kg/dose for 1 dose, then 6-12 mg/kg/day for 10-12 weeks following negative CSF culture",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      HIV-exposed/-infected:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <i>",
"      CNS disease (alternative therapy in patients intolerant of amphotericin B):",
"     </i>",
"     Induction: 12 mg/kg/dose for 1 dose, then 6-12 mg/kg/day (maximum: 800 mg/day) for &ge;2 weeks (in combination with flucytosine) (CDC, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Consolidation: 10-12 mg/kg/day for 8 weeks (Perfect, 2010)",
"     <b>",
"      or",
"     </b>",
"     12 mg/kg/dose for 1 dose, then 6-12 mg/kg/day (maximum: 800 mg/day) for 8 weeks (CDC, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Maintenance (suppression): 6 mg/kg/day (maximum: 200 mg/day) (CDC, 2009; Perfect, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <i>",
"      Non-CNS disease, disseminated (including severe pulmonary disease) (alternative therapy; unlabeled use):",
"     </i>",
"     Induction: 12 mg/kg/dose for 1 dose, then 6-12 mg/kg/day (maximum: 600 mg/day) (CDC, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <i>",
"      Non-CNS disease, localized (including isolated pulmonary disease) (unlabeled use):",
"     </i>",
"     12 mg/kg/dose for 1 dose, then 6-12 mg/kg/day (maximum: 600 mg/day).",
"     <b>",
"      Note:",
"     </b>",
"     Duration depends upon infection site and severity (CDC, 2009). For patients with pulmonary disease (not delineated by severity), the IDSA recommends a duration of 6-12 months (Perfect, 2010).",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F171683\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F171684\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Manufacturer&rsquo;s recommendation:",
"     <b>",
"      Note:",
"     </b>",
"     Renal function estimated using the Cockcroft-Gault formula",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     No adjustment for vaginal candidiasis single-dose therapy",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     For multiple dosing in adults, administer loading dose of 50-400 mg, then adjust daily doses as follows (dosage reduction in children should parallel adult recommendations): Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &le;50 mL/minute (no dialysis): Administer 50% of recommended dose daily",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;\">",
"     Intermittent hemodialysis (IHD): Dialyzable (50%): May administer 100% of daily dose (according to indication) after each dialysis session. Alternatively, doses of 200-400 mg every 48-72 hours",
"     <b>",
"      or",
"     </b>",
"     100- 200 mg every 24 hours have been recommended.",
"     <b>",
"      Note:",
"     </b>",
"     Dosing dependent on the assumption of  3 times/week, complete IHD sessions (Heintz, 2009).",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;\">",
"     Continuous renal replacement therapy (CRRT) (Heintz, 2009; Trotman, 2005): Drug clearance is highly dependent on the method of renal replacement, filter type, and flow rate. Appropriate dosing requires close monitoring of pharmacologic response, signs of adverse reactions due to drug accumulation, as well as drug concentrations in relation to target trough (if appropriate). The following are general recommendations only (based on dialysate flow/ultrafiltration rates of 1-2 L/hour and minimal residual renal function) and should not supersede clinical judgment:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     CVVH: Loading dose of 400-800 mg followed by 200-400 mg every 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     CVVHD/CVVHDF: Loading dose of 400-800 mg followed by 400-800 mg every 24 hours (CVVHD or CVVHDF)",
"     <b>",
"      or",
"     </b>",
"     800 mg every 24 hours (CVVHDF)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Higher maintenance doses of 400 mg every 24 hours (CVVH), 800 mg every 24 hours (CVVHD), and 500-600 mg every 12 hours (CVVHDF) may be considered when treating resistant organisms and/or when employing combined ultrafiltration and dialysis flow rates of &ge;2 L/hour for CVVHD/CVVHDF (Heintz, 2009; Trotman, 2005).",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15881445\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer's labeling; use with caution.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F171652\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infusion, premixed iso-osmotic dextrose solution: 200 mg (100 mL); 400 mg (200 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infusion, premixed iso-osmotic sodium chloride solution: 100 mg (50 mL); 200 mg (100 mL); 400 mg (200 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infusion, premixed iso-osmotic sodium chloride solution [preservative free]: 200 mg (100 mL); 400 mg (200 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Powder for suspension, oral: 10 mg/mL (35 mL); 40 mg/mL (35 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Diflucan&reg;: 10 mg/mL (35 mL); 40 mg/mL (35 mL) [contains sodium benzoate, sucrose; orange flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 50 mg, 100 mg, 150 mg, 200 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Diflucan&reg;: 50 mg, 100 mg, 150 mg, 200 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F171637\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F171656\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     I.V.: Do not use if cloudy or precipitated. Infuse over ~1-2 hours; do not exceed 200 mg/hour.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Oral: May be administered without regard to meals.",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F171737\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     W, LR, NS.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Acyclovir, aldesleukin, allopurinol, amifostine, amikacin, aminophylline, amiodarone, ampicillin/sulbactam, anidulafungin, aztreonam, benztropine, bivalirudin, caspofungin, cefazolin, cefepime, cefotetan, cefoxitin, chlorpromazine, cimetidine, cisatracurium, daptomycin, dexamethasone sodium phosphate, dexmedetomidine, diltiazem, dimenhydrinate, diphenhydramine, dobutamine, docetaxel, dopamine, doripenem, doxorubicin liposome, droperidol, etoposide phosphate, famotidine, fenoldopam, filgrastim, fludarabine, foscarnet, gallium nitrate, ganciclovir, gemcitabine, gentamicin, granisetron, heparin, hetastarch in lactate electrolyte injection (Hextend&reg;), hydrocortisone sodium phosphate, immune globulin intravenous, leucovorin calcium, linezolid, lorazepam, melphalan, meperidine, meropenem, metoclopramide, metronidazole, midazolam, morphine, nafcillin, nitroglycerin, ondansetron, oxacillin, paclitaxel, pancuronium, pemetrexed, penicillin G potassium, phenytoin, piperacillin/tazobactam, prochlorperazine edisylate, promethazine, propofol, quinupristin/dalfopristin, ranitidine, remifentanil, sargramostim, tacrolimus, telavancin, teniposide, theophylline, thiotepa, ticarcillin/clavulanate, tigecycline, tobramycin, vancomycin, vasopressin, vecuronium, vinorelbine, zidovudine.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Amphotericin B cholesteryl sulfate complex, ampicillin, calcium gluconate, cefotaxime, ceftriaxone, cefuroxime, chloramphenicol, diazepam, digoxin, erythromycin lactobionate, furosemide, haloperidol, hydroxyzine, imipenem/cilastatin, pantoprazole, pentamidine, sulfamethoxazole/trimethoprim.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Amphotericin B, anakinra, ceftazidime, clindamycin, piperacillin.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F171655\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of candidiasis (esophageal, oropharyngeal, peritoneal, urinary tract, vaginal); systemic candida infections (eg, candidemia, disseminated candidiasis, and pneumonia); cryptococcal meningitis; antifungal prophylaxis in allogeneic bone marrow transplant recipients",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F10579044\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Cryptococcal pneumonia; candidal intertrigo",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F171739\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Fluconazole may be confused with flecainide, FLUoxetine, furosemide, itraconazole, voriconazole",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Diflucan&reg; may be confused with diclofenac, Diprivan&reg;, disulfiram",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      International issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Canesten (oral capsules) [Great Britain] may be confused with Canesten brand name for clotrimazole (various dosage forms) [multiple international markets]; Cenestin brand name estrogens (conjugated A/synthetic) [U.S., Canada]",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F171728\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not always defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Angioedema (rare)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Headache (2% to 13%), dizziness (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Rash (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Nausea (2% to 7%), abdominal pain (2% to 6%), vomiting (2% to 5%), diarrhea (2% to 3%), dysgeusia (1%), dyspepsia (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Alkaline phosphatase increased, ALT increased, AST increased, hepatic failure (rare), hepatitis, jaundice",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Anaphylactic reactions (rare)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Postmarketing and/or case reports: Agranulocytosis, alopecia, cholestasis, diaphoresis, drug eruption, exanthematous pustulosis, fatigue, fever, hypercholesterolemia,  hypertriglyceridemia, hypokalemia, insomnia, leukopenia, malaise, myalgia, neutropenia, paresthesia, QT prolongation, seizure, somnolence, Stevens-Johnson syndrome, thrombocytopenia, torsade de pointes, toxic epidermal necrolysis, tremor, vertigo, weakness, xerostomia",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F171659\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to fluconazole or any component of the formulation (cross-reaction with other azole antifungal agents may occur, but has not been established; use caution); coadministration of CYP3A4 substrates which may lead to QT",
"     <sub>",
"      c",
"     </sub>",
"     prolongation (eg, cisapride, pimozide, or quinidine)",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F171641\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS effects: May occasionally cause dizziness or seizures; use caution driving or operating machinery.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Skin reactions: Rare exfoliative skin disorders have been observed; monitor closely if rash develops and discontinue if lesions progress.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Arrhythmias: Cases of QT",
"     <sub>",
"      c",
"     </sub>",
"     prolongation and torsade de pointes associated with fluconazole use have been reported (usually high dose or in combination with agents known to prolong the QT interval); use caution in patients with concomitant medications or conditions which are arrhythmogenic.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Serious (and rarely fatal) hepatic toxicity (eg, hepatitis, cholestasis, fulminant failure) has been observed with azole therapy. Use with caution in patients with pre-existing hepatic impairment; monitor liver function closely and dosage adjustment may be warranted; discontinue if symptoms consistent with liver disease develop.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment; dosage adjustment may be necessary.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; High potential for interactions: Use caution in patients treated with medications having a narrow therapeutic window and which are metabolized via CYP2C9 or CYP3A4 (monitor). Use with erythromycin should be avoided (may increase risk of cardiotoxicity).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sucrose: Oral suspension contains sucrose; avoid use in patients with fructose intolerance, glucose-galactose malabsorption, or sucrase-isomaltase insufficiency.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F171724\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP1A2 (weak), CYP2C19 (strong), CYP2C9 (strong), CYP3A4 (moderate)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F171646\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alfentanil: Fluconazole may decrease the metabolism of Alfentanil.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphotericin B: Antifungal Agents (Azole Derivatives, Systemic) may diminish the therapeutic effect of Amphotericin B.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aprepitant: Antifungal Agents (Azole Derivatives, Systemic) may decrease the metabolism of Aprepitant.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     AtorvaSTATin: Fluconazole may increase the serum concentration of AtorvaSTATin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Avanafil: Fluconazole may increase the serum concentration of Avanafil.  Management: Limit avanafil to a maximum dose of 50 mg per 24-hour period in any patient who is also receiving a moderate inhibitor of CYP3A4 such as fluconazole.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Benzodiazepines (metabolized by oxidation): Antifungal Agents (Azole Derivatives, Systemic) may decrease the metabolism of Benzodiazepines (metabolized by oxidation).  Management: The following combinations are specifically contraindicated: itraconazole with alprazolam, estazolam, oral midazolam, or triazolam; ketoconazole with alprazolam, estazolam, or triazolam.  Consider initial dose reductions of other benzodiazepines.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Quazepam.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bosentan: Antifungal Agents (Azole Derivatives, Systemic) may decrease the metabolism of Bosentan.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bosutinib: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Bosutinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Budesonide (Systemic, Oral Inhalation): CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Budesonide (Systemic, Oral Inhalation).  Management: Consider reducing the oral budesonide dose when used together with a CYP3A4 inhibitor.  This interaction is likely less severe with orally inhaled budesonide.  Monitor patients closely for signs/symptoms of corticosteroid excess.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BusPIRone: Antifungal Agents (Azole Derivatives, Systemic) may decrease the metabolism of BusPIRone.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Busulfan: Antifungal Agents (Azole Derivatives, Systemic) may decrease the metabolism of Busulfan.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Channel Blockers: Antifungal Agents (Azole Derivatives, Systemic) may enhance the adverse/toxic effect of Calcium Channel Blockers. Specifically, itraconazole may enhance the negative inotropic effects of verapamil or diltiazem. Antifungal Agents (Azole Derivatives, Systemic) may decrease the metabolism of Calcium Channel Blockers.  Management: Concurrent use of felodipine or nisoldipine with itraconazole is specifically contraindicated.  Frequent monitoring is warranted with any such combination; calcium channel blocker dose reductions may be required.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Clevidipine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Channel Blockers: Fluconazole may decrease the metabolism of Calcium Channel Blockers.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Clevidipine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CarBAMazepine: Fluconazole may increase the serum concentration of CarBAMazepine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Carvedilol: CYP2C9 Inhibitors (Strong) may increase the serum concentration of Carvedilol. Specifically, concentrations of the S-carvedilol enantiomer may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cilostazol: Antifungal Agents (Azole Derivatives, Systemic) may decrease the metabolism of Cilostazol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cinacalcet: Antifungal Agents (Azole Derivatives, Systemic) may decrease the metabolism of Cinacalcet.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cisapride: Antifungal Agents (Azole Derivatives, Systemic) may increase the serum concentration of Cisapride.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Citalopram: Fluconazole may increase the serum concentration of Citalopram.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Clopidogrel: CYP2C19 Inhibitors (Strong) may decrease serum concentrations of the active metabolite(s) of Clopidogrel.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Colchicine: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Colchicine.  Management: Reduce colchicine dose as directed when using with a moderate CYP3A4 inhibitor, and increase monitoring for colchicine-related toxicity.  Use extra caution in patients with impaired renal and/or hepatic function.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Conivaptan: Antifungal Agents (Azole Derivatives, Systemic) may decrease the metabolism of Conivaptan.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Systemic): Antifungal Agents (Azole Derivatives, Systemic) may decrease the metabolism of Corticosteroids (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Systemic): Fluconazole may decrease the metabolism of Corticosteroids (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CycloSPORINE (Systemic): Fluconazole may increase the serum concentration of CycloSPORINE (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C19 Substrates: CYP2C19 Inhibitors (Strong) may decrease the metabolism of CYP2C19 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C9 Substrates: CYP2C9 Inhibitors (Strong) may decrease the metabolism of CYP2C9 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Substrates: CYP3A4 Inhibitors (Moderate) may decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Diclofenac (Systemic): CYP2C9 Inhibitors (Strong) may increase the serum concentration of Diclofenac (Systemic).  Management: Consider using a lower dose of diclofenac when used together with a strong CYP2C9 inhibitor.  Arthrotec (diclofenac and misoprostol) labeling specifically recommends limiting the total daily dose to a maximum of 50 mg twice/day.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Didanosine: May decrease the absorption of Antifungal Agents (Azole Derivatives, Systemic). Enteric coated didanosine capsules are not expected to affect these antifungals.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     DOCEtaxel: Antifungal Agents (Azole Derivatives, Systemic) may decrease the metabolism of DOCEtaxel.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dofetilide: Antifungal Agents (Azole Derivatives, Systemic) may decrease the metabolism of Dofetilide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Eletriptan: Fluconazole may decrease the metabolism of Eletriptan.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Eplerenone: Fluconazole may increase the serum concentration of Eplerenone.  Management: Reduce the starting dose of eplerenone to 25 mg/day; monitor patients closely for increased eplerenone effects.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Erlotinib: Antifungal Agents (Azole Derivatives, Systemic) may decrease the metabolism of Erlotinib.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Eszopiclone: Antifungal Agents (Azole Derivatives, Systemic) may decrease the metabolism of Eszopiclone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Etravirine: May decrease the serum concentration of Antifungal Agents (Azole Derivatives, Systemic). This would be anticipated with itraconazole or ketoconazole. Etravirine may increase the serum concentration of Antifungal Agents (Azole Derivatives, Systemic). This would be anticipated with voriconazole. Antifungal Agents (Azole Derivatives, Systemic) may increase the serum concentration of Etravirine. Management: Monitor for increased effects/toxicity of etravirine.  Antifungal dose adjustment may be needed for ketoconazole, itraconazole, or posaconazole but specific dosing guidelines are lacking.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Everolimus: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Everolimus.  Management: Everolimus dose reductions are required for patients being treated for subependymal giant cell astrocytoma or renal cell carcinoma.  See prescribing information for specific dose adjustment and monitoring recommendations.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     FentaNYL: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of FentaNYL.  Management: Monitor patients extra closely for several days following initiation of the combination, and fentanyl dosage reductions should be made as appropriate.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fluvastatin: Fluconazole may increase the serum concentration of Fluvastatin.  Management: Limit fluvastatin maximum  adult dose to 20 mg/day, and monitor for toxic effects of fluvastatin (e.g., myalgia, rhabdomyolysis, liver function test abnormalities), during concomitant treatment.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosaprepitant: Antifungal Agents (Azole Derivatives, Systemic) may increase the serum concentration of Fosaprepitant. Specifically, concentrations of aprepitant are likely to be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosphenytoin: Fluconazole may increase the serum concentration of Fosphenytoin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Gefitinib: Antifungal Agents (Azole Derivatives, Systemic) may decrease the metabolism of Gefitinib.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Grapefruit Juice: May increase the serum concentration of Antifungal Agents (Azole Derivatives, Systemic). This specifically applies to oral antifungal administration, and the interaction may be different depending on specific dosage form being used.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Halofantrine: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Halofantrine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Highest Risk QTc-Prolonging Agents: QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying) may enhance the QTc-prolonging effect of Highest Risk QTc-Prolonging Agents.  Management: Avoid such combinations when possible.  Use should be accompanied by close monitoring for evidence of QT prolongation or other alterations of cardiac rhythm.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ifosfamide: CYP3A4 Inhibitors (Moderate) may decrease serum concentrations of the active metabolite(s) of Ifosfamide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Imatinib: Antifungal Agents (Azole Derivatives, Systemic) may increase the serum concentration of Imatinib.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Irbesartan: Fluconazole may decrease the metabolism of Irbesartan.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Irinotecan: Antifungal Agents (Azole Derivatives, Systemic) may enhance the adverse/toxic effect of Irinotecan.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivabradine: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Ivabradine.  Management: In patients with a resting heart rate over 60 beats per minute receiving a moderate CYP3A4 inhibitor, ivabradine initiation at an adult dose of 2.5 mg twice daily may be considered.  Monitor heart rate closely under these circumstances.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivacaftor: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Ivacaftor.  Management: Decrease ivacaftor dose to 150 mg daily in patients also receiving moderate CYP3A4 inhibitors.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lomitapide: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Lomitapide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Losartan: Fluconazole may decrease the metabolism of Losartan.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lovastatin: Fluconazole may increase the serum concentration of Lovastatin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lurasidone: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Lurasidone.  Management: U.S. labeling: start at 20 mg/day and limit to max of 80 mg/day with moderate CYP3A4 inhibitor.  Canadian labeling: limit to max of 40 mg/day with moderate CYP3A4 inhibitor; avoid concomitant use of grapefruit products.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Macrolide Antibiotics: May decrease the metabolism of Antifungal Agents (Azole Derivatives, Systemic). Antifungal Agents (Azole Derivatives, Systemic) may decrease the metabolism of Macrolide Antibiotics.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Azithromycin (Systemic); Fidaxomicin; Spiramycin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methadone: Fluconazole may increase the serum concentration of Methadone.  Management: Methadone dose reduction may be necessary when used with fluconazole.  With any concurrent use, monitor patients closely for evidence of methadone toxicities such as QT-prolongation or respiratory depression.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May enhance the QTc-prolonging effect of QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying). Management: Though the drugs listed here have uncertain QT-prolonging effects, they all have some possible association with QT prolongation and should generally be avoided when possible.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Moderate Risk QTc-Prolonging Agents: QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying) may enhance the QTc-prolonging effect of Moderate Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nevirapine: Fluconazole may increase the serum concentration of Nevirapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ospemifene: Fluconazole may increase the serum concentration of Ospemifene.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phenytoin: Fluconazole may increase the serum concentration of Phenytoin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimecrolimus: CYP3A4 Inhibitors (Moderate) may decrease the metabolism of Pimecrolimus.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimozide: Antifungal Agents (Azole Derivatives, Systemic) may decrease the metabolism of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Propafenone: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Propafenone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Proton Pump Inhibitors: Fluconazole may increase the serum concentration of Proton Pump Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QuiNIDine: Fluconazole may decrease the metabolism of QuiNIDine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ramelteon: Fluconazole may decrease the metabolism of Ramelteon.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ranolazine: Antifungal Agents (Azole Derivatives, Systemic) may decrease the metabolism of Ranolazine.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Red Yeast Rice: Fluconazole may increase the serum concentration of Red Yeast Rice. Specifically, concentrations of lovastatin and related compounds found in Red Yeast Rice may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Repaglinide: Antifungal Agents (Azole Derivatives, Systemic) may increase the serum concentration of Repaglinide.  Management: Concurrent use of an azole antifungal with both repaglinide and gemfibrozil should be avoided.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rifamycin Derivatives: May decrease the serum concentration of Antifungal Agents (Azole Derivatives, Systemic). Antifungal Agents (Azole Derivatives, Systemic) may increase the serum concentration of Rifamycin Derivatives. Only rifabutin appears to be affected.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rifamycin Derivatives: Fluconazole may decrease the metabolism of Rifamycin Derivatives. This appears only affect rifabutin. Rifamycin Derivatives may increase the metabolism of Fluconazole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Saccharomyces boulardii: Antifungal Agents may diminish the therapeutic effect of Saccharomyces boulardii.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Salmeterol: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Salmeterol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Saxagliptin: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Saxagliptin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sildenafil: Fluconazole may increase the serum concentration of Sildenafil.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Simvastatin: Fluconazole may increase the serum concentration of Simvastatin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sirolimus: Fluconazole may increase the serum concentration of Sirolimus.  Management: Sirolimus dose adjustments will likely be needed when starting/stopping any azole antifungal.  Clinical data suggest sirolimus (adult) dose reductions of 50-90% will be needed when starting an azole antifungal, but specific guidelines are lacking.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Solifenacin: Antifungal Agents (Azole Derivatives, Systemic) may decrease the metabolism of Solifenacin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sulfonylureas: Fluconazole may increase the serum concentration of Sulfonylureas.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     SUNItinib: Antifungal Agents (Azole Derivatives, Systemic) may decrease the metabolism of SUNItinib.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tacrolimus (Systemic): Fluconazole may decrease the metabolism of Tacrolimus (Systemic).  Management: Monitor tacrolimus concentrations closely and adjust dose as necessary when concomitantly administered with fluconazole.  Reduced doses of fluconazole will likely be required.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tacrolimus (Topical): Fluconazole may decrease the metabolism of Tacrolimus (Topical).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tadalafil: Fluconazole may increase the serum concentration of Tadalafil.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Temsirolimus: Fluconazole may increase serum concentrations of the active metabolite(s) of Temsirolimus.  Management: Consider temsirolimus dose reductions or alternatives to fluconazole.  Monitor sirolimus concentrations in all patients receiving fluconazole or any systemic azole antifungal.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tipranavir: Fluconazole may increase the serum concentration of Tipranavir.  Management: Limit fluconazole adult maximum dose to 200 mg/day in patients treated with tipranavir.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tofacitinib: Fluconazole may increase the serum concentration of Tofacitinib.  Management: Reduce the adult dose of tofacitinib to 5 mg daily in patients receiving moderate CYP3A4 inhibitors that strongly inhibit CYP2C19 (e.g., fluconazole, sitaxentan).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tolterodine: Fluconazole may decrease the metabolism of Tolterodine. This is likely only of concern in CYP2D6-deficient patients (ie, \"poor metabolizers\")",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tolvaptan: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Tolvaptan.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vardenafil: Fluconazole may increase the serum concentration of Vardenafil.  Management: Limit vardenafil doses to a maximum of 5 mg per 24-hour period in patients receiving concurrent therapy with a moderate CYP3A4 inhibitor such as fluconazole.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vilazodone: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Vilazodone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Fluconazole may increase the serum concentration of Vitamin K Antagonists.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Voriconazole: Fluconazole may increase the serum concentration of Voriconazole.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zidovudine: Fluconazole may decrease the metabolism of Zidovudine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ziprasidone: Antifungal Agents (Azole Derivatives, Systemic) may decrease the metabolism of Ziprasidone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: Fluconazole may increase the serum concentration of Zolpidem.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zuclopenthixol: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Zuclopenthixol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F171648\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (single dose for vaginal candidiasis)/D (all other indications) (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F171662\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events have been observed in some animal reproduction studies. When used in high doses, fluconazole is teratogenic in animal studies. Following exposure during the first trimester, case reports have noted similar malformations in humans when used in higher doses (400 mg/day) over extended periods of time (Aleck, 1997). Abnormalities reported include abnormal facies, abnormal calvarial development, arthrogryposis, brachycephaly, cleft palate, congenital heart disease, femoral bowing, thin ribs and long bones. Use of lower doses (150 mg as a single dose) does not suggest an increase risk to the fetus. Most azole antifungals, including fluconazole, are recommended to be avoided during pregnancy (Pappas, 2009).",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F171690\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/use caution (AAP rates &ldquo;compatible&rdquo;; AAP 2001 update pending)",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F171663\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Fluconazole is excreted in breast milk. The manufacturer recommends that caution be exercised when administering fluconazole to nursing women. Fluconazole is found in breast milk at concentrations similar to maternal plasma.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F171664\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Take without regard to meals.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F171661\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Fluconazole in Dextrose Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     200 mg/100 mL (100 mL): $13.56",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     400 mg/200 mL (200 mL): $15.13",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Fluconazole in Sodium Chloride Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100 mg/50 mL 0.9% (50 mL): $12.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     200 mg/100 mL 0.9% (100 mL): $11.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     400 mg/200 mL 0.9% (200 mL): $16.55",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension (reconstituted)",
"     </b>",
"     (Diflucan Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg/mL (35 mL): $77.42",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     40 mg/mL (35 mL): $267.80",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension (reconstituted)",
"     </b>",
"     (Fluconazole Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg/mL (35 mL): $35.71",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     40 mg/mL (35 mL): $129.70",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Diflucan Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     50 mg (30): $345.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100 mg (30): $542.09",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     150 mg (12): $345.12",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     200 mg (30): $887.09",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Fluconazole Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     50 mg (30): $167.13",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100 mg (30): $262.62",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     150 mg (12): $167.90",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     200 mg (30): $429.75",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F171650\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Periodic liver function tests (AST, ALT, alkaline phosphatase) and renal function tests, potassium",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F171665\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Afungil (MX);",
"     </li>",
"     <li>",
"      Avezol (MY);",
"     </li>",
"     <li>",
"      Baten (CR, DO, GT, HN, NI, PA, SV);",
"     </li>",
"     <li>",
"      Biozole (MY);",
"     </li>",
"     <li>",
"      Candizole (BE);",
"     </li>",
"     <li>",
"      Canesoral (AU);",
"     </li>",
"     <li>",
"      Cryptal (ID);",
"     </li>",
"     <li>",
"      Diflucan (AT, AU, BB, BE, BF, BG, BJ, BM, BS, BZ, CH, CI, CL, CN, CR, CZ, DE, DK, DO, EC, EE, ES, ET, FI, GB, GH, GM, GN, GT, GY, HK, HN, HR, HU, ID, IE, IT, JM, JP, KE, KP, LR, LU, MA, ML, MR, MT, MU, MW, MX, MY, NE, NG, NI, NL, NO, NZ, PA, PE, PH, PL, PT, RU, SC, SD, SE, SK, SL, SN, SR, SV, TH, TN, TR, TT, TW, TZ, UG, ZA, ZM, ZW);",
"     </li>",
"     <li>",
"      DiflucanOne (AU);",
"     </li>",
"     <li>",
"      Difluvid (MY);",
"     </li>",
"     <li>",
"      Difluzole (KP);",
"     </li>",
"     <li>",
"      Difnazol (KP);",
"     </li>",
"     <li>",
"      Dimycon (HR);",
"     </li>",
"     <li>",
"      Dizole One (AU);",
"     </li>",
"     <li>",
"      Dyzolor (PH);",
"     </li>",
"     <li>",
"      Flocan (KP);",
"     </li>",
"     <li>",
"      FLU-D (TW);",
"     </li>",
"     <li>",
"      Flucand (AE, BH, CY, EG, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);",
"     </li>",
"     <li>",
"      Flucanol (IL);",
"     </li>",
"     <li>",
"      Flucazol (AE, BH, BR, CY, EG, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);",
"     </li>",
"     <li>",
"      Flucazole (NZ);",
"     </li>",
"     <li>",
"      Flucess (MY);",
"     </li>",
"     <li>",
"      Flucogus (TW);",
"     </li>",
"     <li>",
"      Flucon (KP);",
"     </li>",
"     <li>",
"      Flucona (KP);",
"     </li>",
"     <li>",
"      Flucoral (ID);",
"     </li>",
"     <li>",
"      Flucoran (NZ);",
"     </li>",
"     <li>",
"      Flucoxan (MX);",
"     </li>",
"     <li>",
"      Flucozal (BR, PK);",
"     </li>",
"     <li>",
"      Fludicon (HK);",
"     </li>",
"     <li>",
"      Fludizol (TH);",
"     </li>",
"     <li>",
"      Flumax (KP);",
"     </li>",
"     <li>",
"      Flunazole (TW);",
"     </li>",
"     <li>",
"      Flunco (TH);",
"     </li>",
"     <li>",
"      Fluxar (ID);",
"     </li>",
"     <li>",
"      Fluzin (KP);",
"     </li>",
"     <li>",
"      Fluzole (AU);",
"     </li>",
"     <li>",
"      Fluzone (BF, BJ, CI, ET, GH, GM, GN, KE, LR, MA, ML, MR, MU, MW, NE, NG, SC, SD, SL, SN, TN, TZ, UG, ZM, ZW);",
"     </li>",
"     <li>",
"      Fluzoral (TH);",
"     </li>",
"     <li>",
"      Forcan (IN);",
"     </li>",
"     <li>",
"      Fukole (MY, PH);",
"     </li>",
"     <li>",
"      Fumay (TW);",
"     </li>",
"     <li>",
"      Funazol (KP);",
"     </li>",
"     <li>",
"      Funex (CO);",
"     </li>",
"     <li>",
"      Fungata (AT, DE);",
"     </li>",
"     <li>",
"      Fungostatin (GR);",
"     </li>",
"     <li>",
"      Funzela (PH);",
"     </li>",
"     <li>",
"      Kyrin (TH);",
"     </li>",
"     <li>",
"      Lucon (HK);",
"     </li>",
"     <li>",
"      Medoflucon (CL, SG);",
"     </li>",
"     <li>",
"      Mutum (AR, PE, VE);",
"     </li>",
"     <li>",
"      Mycocyst (BB, BM, BS, BZ, GY, JM, SR, TT);",
"     </li>",
"     <li>",
"      Mycorest (SG);",
"     </li>",
"     <li>",
"      Mycosyst (HU);",
"     </li>",
"     <li>",
"      Neoconal (KP);",
"     </li>",
"     <li>",
"      Nobzol-1 (CO);",
"     </li>",
"     <li>",
"      Nobzol-2 (CO);",
"     </li>",
"     <li>",
"      Odaft (MY, PH);",
"     </li>",
"     <li>",
"      Omastin (SG);",
"     </li>",
"     <li>",
"      Oneflu (KP);",
"     </li>",
"     <li>",
"      Oxifungol (MX);",
"     </li>",
"     <li>",
"      Oxole (AU);",
"     </li>",
"     <li>",
"      Plunazol (KP);",
"     </li>",
"     <li>",
"      Sixanol (PY, UY);",
"     </li>",
"     <li>",
"      Stabilanol (IL);",
"     </li>",
"     <li>",
"      Stalene (TH);",
"     </li>",
"     <li>",
"      Syscan (IN);",
"     </li>",
"     <li>",
"      Tavor (EC);",
"     </li>",
"     <li>",
"      Tinazole (KP);",
"     </li>",
"     <li>",
"      Treflucan (AE, BH, CY, EG, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);",
"     </li>",
"     <li>",
"      Triflucan (FR, IL, TR);",
"     </li>",
"     <li>",
"      Uzol (TW);",
"     </li>",
"     <li>",
"      Zemyc (ID);",
"     </li>",
"     <li>",
"      Zoldicam (MX);",
"     </li>",
"     <li>",
"      Zoleshot (PH)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F171640\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Interferes with fungal cytochrome P450 activity (lanosterol 14-&alpha;-demethylase), decreasing ergosterol synthesis (principal sterol in fungal cell membrane) and inhibiting cell membrane formation",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F171658\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : ~0.6 L/kg; widely throughout body with good penetration into CSF, eye, peritoneal fluid, sputum, skin, and urine",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Relative diffusion blood into CSF: Adequate with or without inflammation (exceeds usual MICs)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     CSF:blood level ratio: Normal meninges: 50% to 90%; Inflamed meninges: ~80%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding, plasma: 11% to 12%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: Oral: &gt;90%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Normal renal function: ~30 hours (range: 20-50 hours); Elderly: ~46 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, serum: Oral: 1-2 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (80% as unchanged drug)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Aleck KA and Bartley DL, &ldquo;Multiple Malformation Syndrome Following Fluconazole Use in Pregnancy: Report of an Additional Patient,&rdquo;",
"      <i>",
"       Am J Med Genet",
"      </i>",
"      , 1997, 72(3):253-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/9332650/pubmed\" id=\"9332650\" target=\"_blank\">",
"        9332650",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      American Academy of Pediatrics Committee on Drugs, \"Transfer of Drugs and Other Chemicals Into Human Milk,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2001, 108(3):776-89.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/11533352/pubmed\" id=\"11533352\" target=\"_blank\">",
"        11533352",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Amichai B and Grunwald MH, &ldquo;Adverse Drug Reactions of the New Oral Antifungal Agents - Terbinafine, Fluconazole, and Itraconazole,&rdquo;",
"      <i>",
"       Int J Dermatol",
"      </i>",
"      , 1998, 37(6):410-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/9646122/pubmed\" id=\"9646122\" target=\"_blank\">",
"        9646122",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Baddour LM, Wilson WR, Bayer AS, et al, &ldquo;Infective Endocarditis. Diagnosis, Antimicrobial Therapy, and Management of Complications: A Statement for Healthcare Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association - Executive Summary:",
"      <i>",
"       Endorsed by the Infectious Diseases Society of America",
"      </i>",
"      ,&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2005, 111:3167-184.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/15956145/pubmed\" id=\"15956145\" target=\"_blank\">",
"        15956145",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Berl T, Wilner KD, Gardner M, et al, &ldquo;Pharmacokinetics of Fluconazole in Renal Failure,&rdquo;",
"      <i>",
"       J Am Soc Nephrol",
"      </i>",
"      , 1995, 6(2):242-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/7579091/pubmed\" id=\"7579091\" target=\"_blank\">",
"        7579091",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bratzler DW, Dellinger EP, Olsen KM, et al, &ldquo;Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery,&rdquo;",
"      <i>",
"       Am J Health Syst Pharm",
"      </i>",
"      , 2013, 70(3):195-283.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/23327981/pubmed\" id=\"23327981\" target=\"_blank\">",
"        23327981",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), &ldquo;Guidelines for Prevention and Treatment of Opportunistic Infections Among HIV-Exposed and HIV-Infected Adults and Adolescents.  Recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America,",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2009, 58(RR-4):1-207.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/19357635/pubmed\" id=\"19357635\" target=\"_blank\">",
"        19357635",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), &ldquo;Guidelines for Prevention and Treatment of Opportunistic Infections Among HIV-Exposed and HIV-Infected Children. Recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics,&rdquo;",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2009, 58(RR-11):1-166.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/19730409/pubmed\" id=\"19730409\" target=\"_blank\">",
"        19730409",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), \"Sexually Transmitted Diseases Treatment Guidelines, 2010,\"",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2010, 59(RR-12):1-110.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/21160459/pubmed\" id=\"21160459\" target=\"_blank\">",
"        21160459",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Chapman SW, Dismukes WE, Proia LA, et al, \"Clinical Practice Guidelines for the Management of Blastomycosis: 2008 Update by the Infectious Diseases Society of America,\"",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2008, 46(12):1801-12.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/18462107/pubmed\" id=\"18462107\" target=\"_blank\">",
"        18462107",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Chen CM, Ho MW, Yu WL, et al,  &ldquo;Fungal Peritonitis in Peritoneal Dialysis Patients: Effect of Fluconazole Treatment and Use of the Twin-Bag Disconnect System,&rdquo;",
"      <i>",
"       J Microbiol Immunol Infect",
"      </i>",
"      , 2004, 37(2):115-20.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/15181494/pubmed\" id=\"15181494\" target=\"_blank\">",
"        15181494",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Coldiron BM and Manders SM, \"Persistent Candida Intertrigo Treated With Fluconazole,\"",
"      <i>",
"       Arch Dermatol",
"      </i>",
"      , 1991, 127(2):165-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/1990982/pubmed\" id=\"1990982\" target=\"_blank\">",
"        1990982",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Como JA and Dismukes WE, &ldquo;Oral Azole Drugs as Systemic Antifungal Therapy,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1993, 330(4):263-72.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/8272088/pubmed\" id=\"8272088\" target=\"_blank\">",
"        8272088",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Edwards JE Jr, Bodey GP, Bowden RA, et al, &ldquo;International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 1997, 25(1):43-59.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/9243032/pubmed\" id=\"9243032\" target=\"_blank\">",
"        9243032",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Eggimann P, Francioli P, Bille J, et al, &ldquo;Fluconazole Prophylaxis Prevents Intra-Abdominal Candidiasis in High-Risk Surgical Patients,&rdquo;",
"      <i>",
"       Crit Care Med",
"      </i>",
"      , 1999, 27(6):1066-72.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/10397206/pubmed\" id=\"10397206\" target=\"_blank\">",
"        10397206",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Force RW, &ldquo;Fluconazole Concentrations in Breast Milk,&rdquo;",
"      <i>",
"       Pediatr Infect Dis J",
"      </i>",
"      , 1995, 14(3):235-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/7761190/pubmed\" id=\"7761190\" target=\"_blank\">",
"        7761190",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Galgiani JN, Ampel NM, Blair JE, et al, &ldquo;Coccidioidomycosis,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2005, 41(9):1217-23.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/16206093/pubmed\" id=\"16206093\" target=\"_blank\">",
"        16206093",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Goa KL and Barradell LB, &ldquo;Fluconazole. An Update of Its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Use in Major Superficial and Systemic Mycoses in Immunocompromised Patients,&rdquo;",
"      <i>",
"       Drugs",
"      </i>",
"      , 1995, 50(4):658-90.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/8536553/pubmed\" id=\"8536553\" target=\"_blank\">",
"        8536553",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Goodman JL, Winston DJ, Greenfield RA, et al, &ldquo;A Controlled Trial of Fluconazole to Prevent Fungal Infections in Patients Undergoing Bone Marrow Transplantation,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1992, 326(13):845-51.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/1542320/pubmed\" id=\"1542320\" target=\"_blank\">",
"        1542320",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gould FK, Denning DW, Elliott TS, et al, &ldquo;Guidelines for the Diagnosis and Antibiotic Treatment of Endocarditis in Adults:  A Report of the Working Party of the British Society for Antimicrobial Chemotherapy,&rdquo;",
"      <i>",
"       J Antimicrob Chemother",
"      </i>",
"      , 2012, 67(2):269-89.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/22086858/pubmed\" id=\"22086858\" target=\"_blank\">",
"        22086858",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Grant SM and Clissold SP, &ldquo;Fluconazole: A Review of Its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Potential in Superficial and Systemic Mycoses,&rdquo;",
"      <i>",
"       Drugs",
"      </i>",
"      , 1990, 39(6):877-916.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/2196167/pubmed\" id=\"2196167\" target=\"_blank\">",
"        2196167",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Heintz BH, Matzke GR, Dager WE, &ldquo;Antimicrobial Dosing Concepts and Recommendations for Critically Ill Adult Patients Receiving Continuous Renal Replacement Therapy or Intermittent Hemodialysis,&rdquo;",
"      <i>",
"       Pharmacotherapy",
"      </i>",
"      , 2009, 29(5):562-77.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/19397464/pubmed\" id=\"19397464\" target=\"_blank\">",
"        19397464",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kauffman CA and Carver PL, &ldquo;Antifungal Agents in the 1990s. Current Status and Future Developments,&rdquo;",
"      <i>",
"       Drugs",
"      </i>",
"      , 1997, 53(4):539-49.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/9098658/pubmed\" id=\"9098658\" target=\"_blank\">",
"        9098658",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kowalsky SF and Dixon DM, &ldquo;Fluconazole: A New Antifungal Agent,&rdquo;",
"      <i>",
"       Clin Pharm",
"      </i>",
"      , 1991, 10(3):179-94.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/2040125/pubmed\" id=\"2040125\" target=\"_blank\">",
"        2040125",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lee JW, Seibel NL, Amantea M, et al, &ldquo;Safety and Pharmacokinetics of Fluconazole in Children With Neoplastic Diseases,&rdquo;",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 1992, 120(6):987-93.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/1593362/pubmed\" id=\"1593362\" target=\"_blank\">",
"        1593362",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lyman CA and Walsh TJ, &ldquo;Systemically Administered Antifungal Agents. A Review of Their Clinical Pharmacology and Therapeutic Applications,&rdquo;",
"      <i>",
"       Drugs",
"      </i>",
"      , 1992, 44(1):9-35.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/1379913/pubmed\" id=\"1379913\" target=\"_blank\">",
"        1379913",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mastroiacovo P, Mazzone T, Botto LD, et al, &ldquo;Prospective Assessment of Pregnancy Outcomes After First-Trimester Exposure to Fluconazole,&rdquo;",
"      <i>",
"       Am J Obstet Gynecol",
"      </i>",
"      , 1996, 175(6):1645-50.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/8987954/pubmed\" id=\"8987954\" target=\"_blank\">",
"        8987954",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mercurio MG and Elewski BE, &ldquo;Thrombocytopenia Caused by Fluconazole Therapy,&rdquo;",
"      <i>",
"       J Am Acad Dermatol",
"      </i>",
"      , 1995, 32(3):525-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/7868733/pubmed\" id=\"7868733\" target=\"_blank\">",
"        7868733",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Moncino MD and Gutman LT, &ldquo;Severe Systemic Cryptococcal Disease in a Child: Review of Prognostic Indicators Predicting Treatment Failure and an Approach to Maintenance Therapy With Oral Fluconazole,&rdquo;",
"      <i>",
"       Pediatr Infect Dis J",
"      </i>",
"      , 1990, 9(5):363-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/2352821/pubmed\" id=\"2352821\" target=\"_blank\">",
"        2352821",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Nozickova M, Koudelkova V, Kulikova Z, et al, \"A Comparison of the Efficacy of Oral Fluconazole, 150 mg/week Versus 50 mg/day, in the Treatment of Tinea Corporis, Tinea Cruris, Tinea Pedis, and Cutaneous Candidosis,\"",
"      <i>",
"       Int J Dermatol",
"      </i>",
"      , 1998, 37(9):703-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/9762826/pubmed\" id=\"9762826\" target=\"_blank\">",
"        9762826",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Pappas PG, Kauffman CA, Andes D, et al, &ldquo;Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2009, 48(5):503-35.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/19191635/pubmed\" id=\"19191635\" target=\"_blank\">",
"        19191635",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Pelz RK, Hendrix CW, Swoboda SM, et al, &ldquo;Double-Blind Placebo-Controlled Trial of Fluconazole to Prevent Candidal Infections in Critically Ill Surgical Patients,&rdquo;",
"      <i>",
"       Ann Surg",
"      </i>",
"      , 2001, 233(4):542-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/11303137/pubmed\" id=\"11303137\" target=\"_blank\">",
"        11303137",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Perfect JR, Dismukes WE, Dromer F, et al, &ldquo;Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2010, 50(3):291-322.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/20047480/pubmed\" id=\"20047480\" target=\"_blank\">",
"        20047480",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Perry CM, Whittington R, and McTavish D, &ldquo;Fluconazole. An Update of Its Antimicrobial Activity, Pharmacokinetic Properties, and Therapeutic Use in Vaginal Candidiasis,&rdquo;",
"      <i>",
"       Drugs",
"      </i>",
"      , 1995, 49(6):984-1006.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/7641607/pubmed\" id=\"7641607\" target=\"_blank\">",
"        7641607",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Pham CP, de Feiter PW, van der Kuy PH, &ldquo;Long QTc Interval and Torsade de Pointes Caused by Fluconazole,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 2006, 40(7):1456-61.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/16849620/pubmed\" id=\"16849620\" target=\"_blank\">",
"        16849620",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Restrepo C, Chacon J, and Manjarres G, &ldquo;Fungal Peritonitis in Peritoneal Dialysis Patients: Successful Prophylaxis With Fluconazole as Demonstrated by Prospective Randomized Control Trial,&rdquo;",
"      <i>",
"       Perit Dial Int",
"      </i>",
"      , 2010, 30(6):619-25.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/20634438/pubmed\" id=\"20634438\" target=\"_blank\">",
"        20634438",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rex JH, Bennett JE, Sugar AM, &ldquo;A Randomized Trial Comparing Fluconazole With Amphotericin B for the Treatment of Candidemia in Patients Without Neutropenia. Candidemia Study Group and the National Institute,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1994, 331(20):1325-30.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/7935701/pubmed\" id=\"7935701\" target=\"_blank\">",
"        7935701",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rex JH, Rinaldi MG, and Pfaller MA.  &ldquo;Resistance of",
"      <i>",
"       Candida",
"      </i>",
"      Species to Fluconazole,&rdquo;",
"      <i>",
"       Antimicrob Agents Chemother",
"      </i>",
"      , 1995, 39(1):1-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/7695288/pubmed\" id=\"7695288\" target=\"_blank\">",
"        7695288",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sanchez JM and Moya G, &ldquo;Fluconazole Teratogenicity,&rdquo;",
"      <i>",
"       Prenat Diagn",
"      </i>",
"      , 1998, 18(8):862-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/9742580/pubmed\" id=\"9742580\" target=\"_blank\">",
"        9742580",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sorensen HT, Nielsen GL, Olesen C, et al, &ldquo;Risk of Malformations and Other Outcomes in Children Exposed to Fluconazole",
"      <i>",
"       in utero",
"      </i>",
"      ,&rdquo;",
"      <i>",
"       Br J Clin Pharmacol",
"      </i>",
"      , 1999, 48(2):234-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/10417502/pubmed\" id=\"10417502\" target=\"_blank\">",
"        10417502",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Stengel F, Robles-Soto M, Galimberti R, et al, \"Fluconazole Versus Ketoconazole in the Treatment of Dermatophytoses and Cutaneous Candidiasis,\"",
"      <i>",
"       Int J Dermatol",
"      </i>",
"      , 1994, 33(10):726-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/8002145/pubmed\" id=\"8002145\" target=\"_blank\">",
"        8002145",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Terrell CL, &ldquo;Antifungal Agents. Part II. The Azoles,&rdquo;",
"      <i>",
"       Mayo Clin Proc",
"      </i>",
"      , 1999, 74(1):78-100.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/9987539/pubmed\" id=\"9987539\" target=\"_blank\">",
"        9987539",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Trepanier EF and Amsden GW, &ldquo;Current Issues in Onchomycosis,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 1998, 32(2):204-14.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/9496407/pubmed\" id=\"9496407\" target=\"_blank\">",
"        9496407",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Trotman RL, Williamson JC, Shoemaker DM, et al, &ldquo;Antibiotic Dosing in Critically Ill Adult Patients Receiving Continuous Renal Replacement Therapy,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2005, 41(8):1159-66.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/16163635/pubmed\" id=\"16163635\" target=\"_blank\">",
"        16163635",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Valtonen M, Tiula E, and Neuvonen PJ, &ldquo;Effect of Continuous Veno-Venous Haemofiltration and Haemodiafiltration on the Elimination of Fluconazole in Patients With Acute Renal Failure,&rdquo;",
"      <i>",
"       J Antimicrob Chemother",
"      </i>",
"      , 1997, 40(5):695-700.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/9421318/pubmed\" id=\"9421318\" target=\"_blank\">",
"        9421318",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Vikram HR and Blair JE.  \"Coccidioidomycosis in Transplant Recipients: A Primer for Clinicians in Nonendemic Areas,\"",
"      <i>",
"       Curr Opin Organ Transplant",
"      </i>",
"      , 2009, 14(6):606-12.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/19812497/pubmed\" id=\"19812497\" target=\"_blank\">",
"        19812497",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Viscoli C, Castagnola E, Fioredda F, et al, &ldquo;Fluconazole in the Treatment of Candidiasis in Immunocompromised Children,&rdquo;",
"      <i>",
"       Antimicrob Agents Chemother",
"      </i>",
"      , 1991, 35(2):365-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/2024968/pubmed\" id=\"2024968\" target=\"_blank\">",
"        2024968",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Vucocevic D, Carey EJ, and Blair JE.  \"Coccidioidomycosis in Liver Transplant Recipients in an Endemic Area,\"",
"      <i>",
"       Am J Transplantation",
"      </i>",
"      , 2011, 11(1):111-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/21087416/pubmed\" id=\"21087416\" target=\"_blank\">",
"        21087416",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wassmann S, Nickenig G, and Bohm M, &ldquo;Long QT Syndrome and Torsade de Pointes in a Patient Receiving Fluconazole,&rdquo;",
"      <i>",
"       Ann Inter Med",
"      </i>",
"      , 1999, 131(10):797.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/12/16586/abstract-text/10577320/pubmed\" id=\"10577320\" target=\"_blank\">",
"        10577320",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8450 Version 54.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.55.141.10-46FA143880-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_12_16586=[""].join("\n");
var outline_f16_12_16586=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F171677\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F171678\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F171730\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F171682\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F171707\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F171683\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F171684\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15881445\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F171652\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F171637\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F171656\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F171737\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F171655\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10579044\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F171739\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F171728\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F171659\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F171641\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F171724\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F171646\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F171648\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F171662\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F171690\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F171663\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F171664\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F171661\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F171650\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F171665\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F171640\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F171658\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8450\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8450|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?29/4/29765?source=related_link\">",
"      Fluconazole: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/43/26297?source=related_link\">",
"      Fluconazole: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_12_16587="PIOPED diagnosis of PE";
var content_f16_12_16587=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F78592&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F78592&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Percentage of patients with pulmonary embolism according to scan category and clinical probability in PIOPED study",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Scan Category",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"3\">",
"        Clinical probability of emboli",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        High",
"       </td>",
"       <td class=\"subtitle2\">",
"        Intermediate",
"       </td>",
"       <td class=\"subtitle2\">",
"        Low",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        High",
"       </td>",
"       <td>",
"        96",
"       </td>",
"       <td>",
"        88",
"       </td>",
"       <td>",
"        56",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Intermediate",
"       </td>",
"       <td>",
"        66",
"       </td>",
"       <td>",
"        28",
"       </td>",
"       <td>",
"        16",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Low",
"       </td>",
"       <td>",
"        40",
"       </td>",
"       <td>",
"        16",
"       </td>",
"       <td>",
"        4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Normal or near normal",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        6",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from PIOPED Investigators, JAMA 1990; 263:2753.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_12_16587=[""].join("\n");
var outline_f16_12_16587=null;
var title_f16_12_16588="CMV effects in transplantation";
var content_f16_12_16588=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F72973&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=11\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F72973&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=11\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Effects of cytomegalovirus in transplant recipients",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Direct effects",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Asymptomatic viral shedding and/or seroconversion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acute \"viral syndromes\" - flu-like or mono-like illness (fever, myalgia)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Leukopenia, thrombocytopenia, fever",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Pneumonitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Infection of allograft",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Hepatitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Pneumonitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Nephritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Myocarditis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Pancreatitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Infection of native tissues",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Retina",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Gastrointestinal tract",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Pancreas",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Encephalitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Adrenalitis and insufficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Indirect effects",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bacterial and fungal superinfection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Activation or accelerated infection due to other viruses (HCV, EBV, HHV6, HSV)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Allograft injury and rejection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Oncogenesis and Proliferative Syndromes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        EBV-associated PTLD",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Accelerated atherogenesis (cardiac)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Bronchiolitis obliterans (lungs)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Toxicities of therapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cost of prophylaxis and therapy",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_12_16588=[""].join("\n");
var outline_f16_12_16588=null;
var title_f16_12_16589="Human TCR delta chain";
var content_f16_12_16589=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F64384&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F64384&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 634px\">",
"   <div class=\"ttl\">",
"    Organization of the human T cell receptor delta chain locus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 614px; height: 159px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    There is one V delta gene within the V alpha region. There are also five genes in V alpha that may rearrange with either J alpha or J delta. There is an additional V delta gene between V alpha and D delta, and one more 3' (to the right) of C delta. There are three D delta, and four J delta genes. There is a single C delta gene.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Moss, PA, Rosenberg, WM, Bell, Jl. The human T cell receptor in health and disease. Ann Rev Immunol 1992; 10:71.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_12_16589=[""].join("\n");
var outline_f16_12_16589=null;
var title_f16_12_16590="Prostaglandin syn AERD";
var content_f16_12_16590=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F76922&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F76922&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Prostaglandin and thromboxane synthesis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 427px; height: 315px; background-image: url(data:image/gif;base64,R0lGODlhqwE7AeYAAP///+Xl5XJycvLy8oCAgAAAADk5Oaurq0BAQMDAwEBm/8DN/4CZ/9bW1rq6uqvFuFVVVcjIyBwcHI+Pj3KljJ2dnezs7EdHRwAz///AwGRkZCoqKv+AgPDz/yp9VDmFX+Dm/9bd2VBz/9DQ0KCz/9DZ/+Dg4P9AQGCA/7rNw/Dw8CAgIDAwMDBZ/5Cm///g4P/w8LCwsKCgoLDA/8jVzv/Q0A4ODnCN/4+1omBgYP8wMCBN//8gIDlf+GSdgHKM8hx1SVWVdQBmM6u465CQkFBQUP8AAHBwcP+goP9wcBAQEICtl0eNav9gYBBA//+QkP+wsP39/dbZ5v9QUP8QEJ29rQ5tPu/v7+rq6rrD6VV19Y+i7ipU+vn5+efn5/T09J2t7ejo6O3t7ff394CX8Pr6+vz8/BxJ+/X19Q4+/Udq9mSA88jO6Dw8PLW1tQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAACrATsBAAf/gACCg4SFhoeIiYqLjI2Oj5CRkpOUlZaXmJmam5ydnp+goaKjpKWmp6ipqqusra6vsLGys7S1tre4ubq7vL2+v8DBwsPExcbHyMnKy8zNzs/Q0dLT1NXW19jZ2tvc3d7f4OHi4+Tl5rELIIPpkQqlJCSWNyWKJTcAIOqG+YTw5//mMLgDsAADg0gYSjE4WEnBAkUL3PkzNFHQQoAYxWFA8RAFCoYMFKDoAIDEDBEiOoR0IQgDCQX3SpZwsWCBCJEkF8xA4VDQDAUi6PU7mRIAgxs8H5YUqa4Dz5FGf8ZU4AJl05AMcrqrWZJozocgeCo4+FPBjIxos2EoIQKEiIs3/8i6g9nBRYsFHXaow/BQBEsFOxgsKKHOBQqjCkCU2AHgZAcQO0gOggmgKmLFjEmkXMDYb2N6GM56pmsYwEejhyMaPUjZ8sW7phksfhwvrW1qCRU4vOhkIYPcD1UD6JmQ4FyldUW0cHcRQEIRHxnsUCqop/PVLQGIUKqgBAoRM/QVV91TtZNB51VftJ5wYYkWFhmAcELztn1pCdUf5FvzYfmBxAlCnlItuNCBftlR1Z9k1SnVHkPANVgSCk48NN5xxl2XHYLsrSbcRSAwsNx9JDZTXHzDsQQAPf9JWNwNfzlI0kvYXceACII8RkhPJ9WYkAv35EWQIHFpCONwwbkDHv9BOHL4UI8LdeAESXHx08GJJWZpDJYXdaBcCzi2iKRzCrQAlXUk7CAScxASuVwL+lS3XHc+AuBUCy2cJaJuJAlkJkktlqAbnRzOSc9FJID5Fghv1qblo5DuSN0kWE5iXaSYZsrIpZRewqmmoIYq6qiklmrqqdiYIAOqrLaqSQIIuCrrrJHASuutuCJia6685rprr8DK+muwxJ46bLHIinpsssxiumyz0Gb5bLTU3jZttdhidG223JazbbfgEjICAQTE0EmsKoxwy7fhgksAAjEkkAMBhrCLSAEAjHDEurG2628hI6xAiArxCpJADASsQEACAMiAQA4mAKBCDg+rAED/AkUUwTAA+KoqyLs5qAuLvf9SS8C+hMTQL7wysJCAqkWokIDARRABQAwjmLCCCTpHjK+tR+SQr7kj91vyv+QasrPOF/ersSAIjJBDETFETAS9ABBg88+xKmHxLCQf3awMRRhCRA5H2LwrAhuz3XAOSiSQdNb0cs1xLWGLnawKcQtigrkqrLCCxQmwIAgR+wZ+sSBHEDCC4QBEfbetCKyabyx5643sCEWwgIDbAKA9yOcyTMwCC+YS4DkCFqvOAtZ2j/A5vJgbrbneO0+T+e3QyiC07rbzLrwzuw9vPC/FH09rAsx/HXwk+i5yhLobc5LzICrIUK6uzyvPbAHkrqAu/76VfOt295coYTQRRMCKdSHJe+8q+SpzrPLvJlBsucq0H0wx9Qh4l80ulrG2MYxeqnqX5Y7wOaK9qwjq4hztCuG73BHiWfGTH6vIRzaOraoIq1pBAlQAwoCpwGPvSpcSLibCwPFsablz28/EFzh1AW5nRCjbCKrGAhOoAHSDoFraCkGA38EPfRoMFviOIL670U12BiuCCZTQvo9hjW1rS8DVPmYzGTbNihdjYNxaJgN1ESGA73qfxFb4OHEN7hAZTKKpCsC8QZCPXLuylQlUF6u5YXFlcsNa0ry4K3LFgAXqclsCmEiuHDDvZYSQgfoQUICI5auJcESiHHlFPjuC0f9rWSMCzySGr6Tx7YuRS0AbI5dIhtkNAIg8mcRcNgKLqWxmXxOZIKjGOJsFTJf10uQmcdVJQdyRXodkQQ5O6DkWrCphCEAdKt3muiu68mLqe90sEdC5gzVTXS2LJtHWOIg2ImAFs8vkMIU3N0rEsXzCXKe71CiJd7oznvLMpyrsqc9+ZoKf/gzoPQVK0H3is6AI/edBE8rQgTb0oZvIQQEmOtHqQfSikpABRSeK0Y5KwgQbXahHR7oCig5wpCiVHkWBmdKWFiIGE12hS2daCBVM1Ig0zSklLZfTnBKgkj3t6cyCGlR6EvWoSE2qUpfK1KY69alQTQthJGGPQkxqOI7/KAGDJHHVgUQ1U07w6iOEM5lCVCoR82iIWb+aKRKgQC+CIMFManITqCAGBSWIyEosEleRjAclSmHATw5TEnWwhSqECAtQhPKTJTHkJSg4K1tLBJ4jDScwgynMYZCyohlwBi9wTYhjQJAQyOQjtPEQQTwcAhmtqkgQilkRY2bQAtpcZ7SSnax9pLQi+IzJTlUZ0ZTWASALaecs13EBSFhSnPUsAEiIcKsCnoPc7CxJQ7rNEgnCOl11WKdAB3IHloQToA415yLNZc0CmlMIpOzltwlyUHa1dN0jsWdGc6lNXot7nSJdqbfVAQ2KHMIZQQilOmchLWoM3N+D/He+JOKt/4HhgyY18WRFg/IsfxPSAd38xiJ4ahN2erInHA1iMTDhMAqWsx87eTi3EI6xjGdM4xrb+MYd9RiO1wnQHWerxz6uFpCDHK0hE7lZRj5yspKs5GIxucnBejKUeyXlKftKpFbuVpWzvDwscxlbW/6ylmaWgxh8bRFhFnOJErBRFhzBosFUczYCSa462/nOeM6znvfMZzxLdKMURQARWIpKOVsjjX1OtKIXzec/A7oAboZzoQ1NjXbqgs0UXUEOSpeINFP6FZbORQKUUDNLotnLnx5GqJXh6VSzYtXJaLWrVQFrZMh61qio9TFujWtT6NoYvO41KX5djGALWxTEJoaxj/8NimQPY9nM9oSzhQHtaHNi2sGotrU1gW1gaHvbmOj2L74NbkuMknioLneryK1ucrC73ZB4QQZq8Ix3w9sQJ9BBvukNgxM0gQNN0AG9jTAIDnAA2Om+9ylOkAEA1IAKADgBEgYBgxcAgOCCMDjCFa4LhgMABkZ4AQ8OYYQMmPzfG+c4Lk7whAxMIQkZOIEgkGBwixvB4Bw4wcGLnXCVj8LfHICCw0fu8AzooOEYB4DGee7zW3h8EBKHOtILvnNhOLqiTZ/F0wVRA6AHfOBUJ4ZGN5r1WdQABoaQt8UF0XBBvGDtwgBpoMt+q5JO9KR0d9URVpr3WcG0ADLt+y1eMPH/Zti0ADgVfCxkDoCYP2OnihcFDJ7AgYZnAO0OfzvhOWDxF5S8BjHPQOW5bvC2v6DmbOdA4XPxU1NH3hM6eAIUpgCAJhSeB6fXARKeIPMM3BwJGeBB0HmAdtkbPQMihwISkgAAJEwhA0lgvqgF9npQUEHobNcBAKAg86VjHOOOj3jbRa/zGvCA3oLgARRMnnRcGLX6mnA5FRh/9CkI3fuCAD/jGQ4DHcAc5UhwAjd3cThXdfCHDZh3dM13AkSHfxfHdvtncoxncJgHcgDAA22HeQeIDTwQfTqAeVRQeA7oby0Xgf2XBAHHAebHAVPQBEPngRuoDSZHccTndmvXdo33/wIwgH5n93HI93Y+iH5sh4MxyA1LV4Sj0oNIuIRMmAp5xQ45QgIM4AJxAgLKRQKSMQMMgIVNWA4iISLxsBgksAAv8RCJ4lkuwBgLcANrKFZdiAmnV3g7CANEuAs98V87cGB2AhkMslXY9YaXYHRQkHONxwP69gs9MR/vYQjQhQgFBoiY0ATYpwPy9oHA8IU7MIYDcQO6UQLNMSiD0AGwAYmX8HQMF36ISBMkMR+SohmEUByi6CikWAlJ8ATpR4eMh4iT4hGT8RCZOAgc1gKyOIuU8AL+p3ONl4u+wCkqMSgooA6KpRv3wADcRSfEWAnIJwg7eI3c2I2EoGPeaB/2lv91JqeBjVeHrNZz4bh9HcgBPDBxSKADHJAEAgcAT6B9H0cFQkht6uiNIqeBNfACVIB5wScIU3BwU2CLTLeOlPAELkgIDkkI5/dxPMB7u9aP3XiEGWeATwcFIXeRDNmQDzkITyB96Yd+OvByIBmSkiCQAOmSbNeAzKcD2KdsGNmNSNCO79h88kiP9BZ8aPdw5phtN+mNM0gIR5l5gxCQC8mSGTGOTkkLUBmVsjCVfVdH6EaVmSBuvmCVeceVveCVdAeWyFOUTkmWuyCWZYeWl2aWLMmWouaWIQmXuKCWWUeX/KKV4fZ+tiaXDImXtmCXTQeYeOOX60iYoaBpMuB6p6b/l5eAmKDQZkdgZo3pmJWAaIyWmZrJZ482UQFEaAZjmOFIZ5tZmqb5U53pZuN0RJY5DRulBJvGmHHWmtFQADUDmtxDm+4mmrrJj70pDoLZK1HQBWMwAMZ5nMiZnMq5nMzZnM75nNAZndI5ndRZndZ5ndiZnG7QBtnZnd75neAZnt6JBl1gBqUQBV+ABQGwnuzZnu75nvAZn/I5n/RZn/Z5n/iZn/q5n/zZn/F5AAbgnwI6oARaoAZqoGEwAFEQCmPgBQf6oBAaoRI6oRQ6nwBaoRiaoRp6oF4wAJ9wBRsaoiI6oiQqoBdaoiiaohtqAQu6CSCqojAaozI6oSc6ozZ6/6P6iQUtigkDgKM++qNA+p41GqRE+qNikAllUKRKuqQlCgGAdgBMGqUqigaYYAFSeqVY+qATAGhZ2qUaGgaXYAZeOqZkep8RsFEBWqZqeqBjYAlfsKZwGqcSQFEEEKd22p9XYAlicKd82qUaQFEO0KeCWp9YYAlWOqiIWqQVMFE2kKiO+p6G+qiSeqMNMFEQMKmSGqmYuqkqagAFMAGcmqiaGqqkGqICUAARUKqCOqqq2qo0KgGuyqesGqu0aqACUKtxOqu4uqu8Sqq62qvAGqyI+qvCWqzGqqbEeqytygZDMARZ0J5g8AM/8KwBkAVSsJ5SQK3RugXXqqw3mqzeSv+qP9ADP6AGWhAAUsAFPzAEYKAFPxAAPTAE6zkEPRAAQ7AG91qv4Tqj4Lqvmyqt68kFQ6AFZNCe1xqv86qv7IkB/iqj/eqjAhCxEjuxFFuxFnuxGJuxGruxHNuxHvuxFQul7gmwAXAGWZAG3dqePeCuP6AFCmuvZ8CeBwCyNFuzNnuzOJuzEZuq+fmwOFoAOhu0QisABmAAQ3u0Fyuy7Tmu43quDBsAW9ADPbAF8EoGzUoGCpuu8rqeM4u0R1u0Xhu2NisBSnufPnujBRCnETumLTsEbLCeJsueAIuw9qqv6Uq1TLq2fWoAZWufZ2ujaQunetulJLueW8AF3Tq3W0v/r+jKBXibt7e6t31bn387o4G7poObpYVruFLbA2ogr3TLuD+QBp1LrUWauXbKt/pZuTJ6uWqKug2robALp6rbs5VwqFHqumU6u3AaAaD6upHLp7WLn6wbo7pLpry7pkM6pslbpsNrtrd7pcfLvMHLp8vrpc1Lps/rt9ErpdOLvdV7p9fbpdk7pttLud2bu2obvnY6vllavl56vvRZvDD6veTLvnHqvlgKv10qv/NJvypqv++Lv3Cqv1fKv1nqv/IJwCkqwPtLwMqbprsLwc47ufObvkJ6AAfQAOwZAQQgABPAwQ2gwRvMng0wAQJQARLqwO5Jwhy8nh4MwiJMwgeQ/6oOIAAEwLMVisD66cId/MEhHAAj7MInnMIHasD46cMwDMQc7AAa3MQ4rMMEysP3ScMaHJ8j3J4VIMMHqsDxmaxAKwASEKgTsAEVcAAEAKsHIAERuwEasJ7kAqAU3J8s3J5hPMYBUMZnnMYBsMYSC6UXUAETYAMvTKFUjJ93TMZmjMZqzMY7G8dGa6BIfJ+JnMeLzMcTIAEQkKqBPMiFPKCHXJ8RC7YE/FMiewAagMoSTKBeDJ9gvJ4VYAARIAGFzME1CgHVO8n7WcfsGbixPMu13Mer3J6tPMVz7J++LMu0bMLCDJ+6bJ/PTJ/JDMzMHADbW8z3Gcr2qbcVoMIB0P/N68nGl+qevGyf2Nyer5zHF0AAb9zCEhwBjcqeAjDOD1rOARC4E7DO7dyefhyxStsANiDFEqrN9YnP+iykG6DBgSrP9Dyg0TyfBs3O8Pm8AC3Q/knQ9Km3DUC2a9zEGwDQLQyrBnrO7AnGAqABY6y3RRugQ3q5DrDMEGrPQIvSNxy5K93HCa3BOozLGYrREH3SKW3TRdvHjvy7AfDSn2yiw0zHQF3T63nT1ly2PG2rx9yfg/vSG7DQGlCngWzCCd3FFvy/GEzOV6zOdtzMMLwB6/nSCx3T+VkAZZ3PZ329ENDQhlzV/AnXIivXvYzW7MnWR7zUeR3XF3DWUc2edf3/oD4tn5m7ARIsAY6tyevZABtg1AVK0uuZzuwpAUadtidK2SoM2Cv81u7J2X29vIktu3i9y6Xd2X591Hgc2AWqu6a9noFbu6l9oIsdn4OrAb79xg6g1kLcqJRt2Zcd1gs81obdwRCw0m98ADZQtGb81BIA1fVM2u0ZAc1dtM8d3UU7AQdQACtt3BG62/Cpu9rt3K9tANU91AX60PKJ3tttAG+sATaQ1eE93lQ9oXpbxkJc2VvNnoEsAN5tAG09oJgdAAyMovaspOYNpPAdpA/uowm+4CXa4Ke72lka4UA64Tha4cpdpBhOpB6Ooxz+oyVuoyBOCbjLpCMu4RqOpScO/7ExLqUrPgktbqAacOBuncQZjqM7LtspGuQFmuL+SeTHvbohzp+1m+DYfZ+CfaNGrp9Njtz7OeP+WeX7DaNaPtJW7spLHgBEewEO4AC/68FiHsuXOss8bQAEcAEXkKrpTeZC3NwQwMGxTOcNYOdJbdv5eat7bgB3nseCzrMpTN+BLrJ5HqgaPAETMOeBGuiD7gAXYADePOY8buSYbuZLnOaCHgBsfqtuDudy3tx6zuffbAB0LqRRrp+bfuZ1euhrrsmi/uZxDuqmHumovujvmeKv3umyDuq0bs22XuqqruuCjufHPtFfDqlL/uZHXQEAzcEnfc+gegEhvAEEAKWITv8Aax6oLx0A6/zNDlABF9AAwDzuFcDjfo7I4l6n657PIyzSnyrucR7u5o7utEzgGvDo4A6r6u4AEbABEdAAfAvt5e6eKY7w0k7IYv7G9Y7tlL3t1qwBDeDtoP7v707u+U7N7kygDD/tD2/t4p7tFN/t3w7bG7/uHQ/T8lzj9RnyDl/tEW/y3G7xGB8BGh/wLd/nNy4JOc6eZTwBCw0BoCoBqRq4a6vlJzoBzZ22EBDInIzLYnwAUV8BFt3ulBwAV8/JImvg97yeepu2F0D1ZDu4Tu+pXC/1AUAARku0IFzZ7J7iQ1/0R5/0Yi/qXw+lTf/0a4/14m72k4vl61n362n/9AGA9GEv5nr/1HyfpmkP9Wxf9hFLtgoP8/Rp+Fx/94u/9HuP1pH/91Nf+ZP785EQ9DKL0rf60ube7p7v+M2sAZu8+E5vAwC67U+cxxBg++eN3bUPoJ+v9JGbtm7uwnor+3iv+7Y/zyScqqjMxpdPo6oP263f+Y1/2BeK/LS/+7evxPzc6vn5/KsvAdUv/IeN/QGq/fjM/cWf++2Z4uJP/YVt/eevutk/++tv++1fwu4JCAYHAYSFhoeEAIqLjI2OABaIhA4NARUGhAYSgwEFhAICAQYVmYMHmKMBEZ6cGqAXhA0RraGInpK4rISuBBoBDRKEt6DCAQKwvxHEoqSr/wG0BxKVAQ6UlpiGy7jb3JOVl5mbxcahqaKmqM26Aa7HsRGIp93z1N/YmpzD5aTnz+mq69ohk3VIG72D1sCJEtfp075S/pgBfLbr1TtEgg4WesTxUSRJFTYY2OCA0IQNhfRZEtlPngMJBjR4EiDSQCUNIjcoqznt0K2DM3k2gLBhAz+VDdnlVFbrZcygBmwGODmyQsiRJbPV0njwKkmTKMcRu9oSk1OZxngqHQnvkDyuIHNmPZnS4UpU6KjBREsz6s2lBbfC5eZ1btikY1lmdLkXqlScbDFy0tix8qKP9CBMGMy528/OoENzMyi6m+bSg9+iNnR69UHSrg+1jj0vI/9Xy5Yxd4sQjDbnz76Dd4MdnLfwbqpdGz+Oizjt5cwl2aaMu6Pu6KuBY4/ufPv25N6Fdw9/fPrB6tbJo9aunvb49r7Bw1/9fv5q8/TQc7xuXyP7/qLVB6Bo8g3YmYAGcobfPPp5lKB/D6KGYIRcFUjha4JdKNqC3TToCH8aGvJfiPNMSCI3Fp7YXIYqwsUhNx42AuKJI7YoiYk2uoVNjqOxyGNtk50X42U/JlXkNjgWmWKRSfL44jZDEvljjUc2yeOSP1pp45O4RKnIjCRSyaSPR26DJY9atsilJF5CUqSYWZJZpiRn5pimimsi0iaYIcKJppxz6hhoYIN2k+che9r/WcCii242qASMLlqoJBBEWkCQRdpg6aSGOGApMvl5yWeEB1jaVqCVMrojpyZtimqkq3KqKaMEUBflqBFGeligE0QK6JyrqDpor7SyWkiqi2YV6q1OMupLoQ1EqqyxAUC6aK2BBpsstVMxasNtovJIAKP8FLrBot9yuwuj05ZpbbrUagsBuMzm6OmiPQ0qUwGgclsBupPuO6+61joqZL05ahproP8WgK260RYw8KANG0ztvqcuOySuEV5QwK9TFpAxtwYUYPGcEY/M6r+92brxj722O6gm6mYjMqc01xztsy7HyPGDEcDLKQET1xwNqwLwrK45PXv484NKT+rAyeqC/5zjAeVWna/GPtfs9ddgg51o2GSXbXaRY5+t9tpsD5h223DHLXdwb89t9914H/xy3nz37XcAdWsYwgMPzPNACjkSHgI3hweawgM0bEPDA4vbqLgkg0fudeNshvsgBUB84AEOhPjwAQU+jB6A6KIHUbkHPgThQYQPWCG6D4Tg4AEFFMAeAOgfBI847LK3KETwHyyeAuwUMDF77cinsAQToFdBu+2+B6A7775/cHwAy1PwAe4nBg9E6B/gQoMQpBNC/Ox6ep4g7wGEAEQKFARhCOIfFK49/K/zn4EekL4AMGEJD/BA5cD3OwocIoAqEgIhpmc/xBECcQQ0ROWqUMAEZf/QgAhUYCEsKMH6ESIEJVQR/QJAAwsOjhDNg58JA+ABAW5EfgZaYQ2BoDlD9K8QTGgfIe73oA/6IH9CLET+CEc5QxDxRCXkIA70d4gPHgIHTKBdAY8YhCQWIoWEoIEVbLTCEHjAeqoLAA95eIgnGiJw/Vli7wJQwgfwrnA/hKEDJ5jFItYQBzz8IQ14Rzrx8Y4CPZye8R5QhTOu8JABgN74ClFB2v0xkIUbJAXaB0YQknGP4ANCEKi4vAD4YAmGUGT8EJbD0+FgcVaI3OSC4MA8mrJ9ulvgAIFAgSVELoj1e8AS0rdCQ+TSeLxD3BKoSDgJWvGEaSwiL31pQNINbpj/hADjKHNUzN+NsXSnK17uRLjKvc0PlL+jYgNX578UAGFxx9SiIRJYuQx283+6JBEYK5nNSHawftEs4j/pSYgPpnCb3ASlO2M3xCoQjo3xLGfXPofOEAThdKkj3QdoKTvEpUAIR6SADQH0zN/trne4MyTvWgjSO0bwEI08ovP8aQjnQVKgh+gd91IqBAcuwQqH7CGJylhDGuKglKVbwkdDOlLA4XBANBDqCTkHPsJZMJhMlGp/QnDVeQpwckwMweCyqqKmVrVyXN0fE81qn7QignCFYCIL15pPDUU1jC6EXA+5OlbCaRWOfwusYMsG2MEa9rCsCkObBoDYxjqWU2Jo6FMZHkvZyv4IDW1yk2U3y9kIeSEKme1CZ0dL2vl8IbOKuEJpV8va42ABtYqIAhZaS9vahuazsI3tbG3L295yAwtlyC0jGOvb4hb3CqAVLiPMcAUvGPe5rL1CF5TbkS58YQDYza52t8vd7nr3u+ANr3jHS97ymve86E2vetfL3va6973wjS93p0vd+tr3vvjNr373y9/++ve/AA6wgAdM4AIb+MAITrCCF8zgBjv4wRCOsIQnTOEKW/jCGM6whjfM4Q57+MMgDrGIR0ziEpv4xChOsYpXzOIWu/jFMI6xjGdM4xrb+Mb+DQQAOw==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Schematic representation of prostaglandin synthetic pathways and the enzymes that catalyze the specific reactions.",
"    <div class=\"footnotes\">",
"     PG: prostaglandin (grey-shaded area); COX: cyclooxygenase (can be subdivided into COX-1, COX-2, and COX-3); Tx: thromboxane.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_12_16590=[""].join("\n");
var outline_f16_12_16590=null;
var title_f16_12_16591="T shaped uterus 3";
var content_f16_12_16591=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F62485&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F62485&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Diethylstilbestrol (DES)-related anomalies: T-shaped uterus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 352px; height: 202px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Pediatric and Adolescent Gynecology, 6th ed, Emans SJ, Laufer MR (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2012. Copyright &copy; 2012 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_12_16591=[""].join("\n");
var outline_f16_12_16591=null;
